image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
991e8baf4cfe77c5f35a819b82da4220438295ccd21f4489a80fdf97898f5dbc.png | complex | <table><tr><td colspan="2">Initial Experiment Results</td><td colspan="2">Enhanced Results</td></tr><tr><td>Total Length Ratio</td><td>RMSE (m)</td><td>Total Length Ratio</td><td>RMSE (m)</td></tr><tr><td>0.94</td><td>3.2</td><td>0.96</td><td>0.93</td></tr></table> | <table><tr><td colspan="2">Initial Experiment Results</td><td colspan="2">Enhanced Results</td></tr><tr><td>Total Length Ratio</td><td>RMSE (m)</td><td>Total Length Ratio</td><td>RMSE (m)</td></tr></table> | <table><tr><td>0.94</td><td>3.2</td><td>0.96</td><td>0.93</td></tr></table> |
4b01d2f9a5dff16bbecc33e5ec35a1bcd29340f37e669562b4b842699a570a1c.png | complex | <table><tr><td></td><td>Acute</td><td>Chronic</td><td>No Pain</td><td><i>p</i> Value</td></tr><tr><td>Total Number (<i>n</i> = 218)</td><td>140 (64)</td><td>33 (15)</td><td>45 (21)</td><td></td></tr><tr><td colspan="4">Age <i>n</i> (%)</td><td rowspan="3">0.897</td></tr><tr><td>19–25</td><td>97 (69)</td><td>23 (7... | <table><tr><td></td><td>Acute</td><td>Chronic</td><td>No Pain</td><td>p Value</td></tr><tr><td>Total Number (n = 218)</td><td>140 (64)</td><td>33 (15)</td><td>45 (21)</td><td></td></tr><tr><td colspan="4">Age n (%)</td><td>0.897</td></tr></table> | <table><tr><td>19–25</td><td>97 (69)</td><td>23 (70)</td><td>33 (73)</td><td rowspan="2">0.897</td></tr><tr><td>26+</td><td>42 (30)</td><td>10 (30)</td><td>12 (27)</td></tr><tr><td colspan="4">Sex n (%)</td><td rowspan="3">0.066</td></tr><tr><td>Male</td><td>50 (36)</td><td>14 (42)</td><td>25 (56)</td></tr><tr><td>Fema... |
aa9cb5a3733d4c0d362cb60d91cb69d1b3c6c801198f7f51a53e82128749f960.png | simple | <table><tr><td> </td><td>White (<i>n</i> = 93,325)</td><td>Black (<i>n</i> = 8,718) </td><td>Hispanic (<i>n</i> = 24,078) </td><td>Asian/Pacific Islander (<i>n</i> = 16,476) </td><td>American Indian (<i>n</i> = 587) </td><td>Total <i>N</i> = 143,184 </td></tr><tr><td>Mean age in years ± SD </td><td>61.49 ± 13... | <table><tr><td></td><td>White (n = 93,325)</td><td>Black (n = 8,718)</td><td>Hispanic (n = 24,078)</td><td>Asian/Pacific Islander (n = 16,476)</td><td>American Indian (n = 587)</td><td>Total N = 143,184</td></tr><tr><td>Mean age in years ± SD</td><td>61.49 ± 13.47</td><td>57.72 ± 13.51</td><td>55.13 ± 13.35</td><td>55.... | <table><tr><td></td><td>White (n = 93,325)</td><td>Black (n = 8,718)</td><td>Hispanic (n = 24,078)</td><td>Asian/Pacific Islander (n = 16,476)</td><td>American Indian (n = 587)</td><td>Total N = 143,184</td></tr><tr><td>ER−/PR+/HER2+</td><td>0.3%</td><td>0.6%</td><td>0.6%</td><td>0.4%</td><td>0.2%</td><td>539</td></tr>... |
67dcc1e5384d5cd26104c79f3a3515f4fe6503364d017a2fc9c8eb37804581c6.png | complex | <table><tr><td>Threshold</td><td>Net benefit</td><td>Point Estimate</td><td>Bootstrap Mean</td><td colspan="2">Bootstrap confidence interval</td></tr><tr><td></td><td>For:</td><td></td><td>(2000 replications)</td><td>2.5<sup>th </sup>percentile</td><td>97.5<sup>th </sup>percentile</td></tr><tr><td>15</td><td>All</td><t... | <table><tr><td>Threshold</td><td>Net benefit</td><td>Point Estimate</td><td>Bootstrap Mean</td><td colspan="2">Bootstrap confidence interval</td></tr><tr><td></td><td>For:</td><td></td><td>(2000 replications)</td><td>2.5th percentile</td><td>97.5th percentile</td></tr><tr><td>15</td><td>All</td><td>0.1288</td><td>0.128... | <table><tr><td></td><td>Full vs Base</td><td>0.0302</td><td>0.0322</td><td>0.0170</td><td>0.0488</td></tr><tr><td>25</td><td>All</td><td>0.0126</td><td>0.0126</td><td>-0.0288</td><td>0.0559</td></tr><tr><td></td><td>Base</td><td>0.0748</td><td>0.0735</td><td>0.0432</td><td>0.1036</td></tr><tr><td></td><td>Full</td><td>... |
eacaa4f7575a8e04e674c7906e7d1d947a5109abc2d7f2a0b91385ba770e7aa1.png | simple | <table><tr><td></td><td>AIM HI</td><td>CPRT</td></tr><tr><td>Initial didactic training—lecture material, video examples, case illustrations, and hands-on practice with coaching and discussion</td><td>12 h (over 2 days)</td><td>8 h</td></tr><tr><td>Ongoing consultation/coaching—occurs while provider delivers... | <table><tr><td></td><td>AIM HI</td><td>CPRT</td></tr><tr><td>Initial didactic training—lecture material, video examples, case illustrations, and hands-on practice with coaching and discussion</td><td>12 h (over 2 days)</td><td>8 h</td></tr><tr><td>Ongoing consultation/coaching—occurs while provider delivers interventio... | <table><tr><td></td><td>AIM HI</td><td>CPRT</td></tr><tr><td>Total length of training</td><td>22 h/6 months</td><td>18 h/6 months</td></tr></table> |
cd648ccf5a84955b30128b0787d84824003da271ffda3815339b1f04bee53665.png | complex | <table><tr><td>Category</td><td>No. of children</td><td>No. of diarrheal episodes</td><td>Total time at risk (years)</td><td>Diarrheal incidence (episodes/child year)</td><td>Unadjusted IRR (95% CI)</td><td>Adjusted IRR* (95% CI)</td><td><i>P</i> value</td></tr><tr><td colspan="8">Study arm</td></tr><tr><td> No interve... | <table><tr><td>Category</td><td>No. of children</td><td>No. of diarrheal episodes</td><td>Total time at risk (years)</td><td>Diarrheal incidence (episodes/child year)</td><td>Unadjusted IRR (95% CI)</td><td>Adjusted IRR* (95% CI)</td><td>P value</td></tr><tr><td colspan="8">Study arm</td></tr><tr><td>No intervention</t... | <table><tr><td>0–6</td><td>94</td><td>37</td><td>40.9</td><td>0.90 (0.65–1.25)</td><td>Ref</td><td>Ref</td><td>–</td></tr><tr><td>6–12</td><td>62</td><td>67</td><td>52.4</td><td>1.28 (1.00–1.62)</td><td>1.32 (0.87–2.00)</td><td>1.30 (0.85–1.98)</td><td>0.222</td></tr><tr><td>12–18</td><td>58</td><td>44</td><td>59.1</td... |
1f08b1af2f364112dca9e9d4692c9242111e94c506f6bd929f8e8b491cbc8e4b.png | simple | <table><tr><td> Factor</td><td><i>n</i></td><td>2-year locoregional failure-free survival</td><td>95% CI</td><td><i>P</i> value</td></tr><tr><td>Age</td><td></td><td></td><td></td><td>0.005</td></tr><tr><td> Age ≤40</td><td>54</td><td>0.86</td><td>0.75–0.98</td><td></td></tr><tr><td> Age >40</td><td>158<... | <table><tr><td>Factor</td></tr><tr><td>Age</td></tr><tr><td>Age ≤40</td></tr><tr><td>Age >40</td></tr><tr><td>Menopausal status</td></tr><tr><td>Premenopausal</td></tr><tr><td>Postmenopausal</td></tr><tr><td>BMI</td></tr><tr><td>BMI <30</td></tr><tr><td>BMI ≥30</td></tr><tr><td>T stage</td></tr><tr><td>Tis, T0–2</td></... | <table><tr><td>n</td><td>2-year locoregional failure-free survival</td><td>95% CI</td><td>P value</td></tr><tr><td></td><td></td><td></td><td>0.005</td></tr><tr><td>54</td><td>0.86</td><td>0.75–0.98</td><td></td></tr><tr><td>158</td><td>0.98</td><td>0.95–1.00</td><td></td></tr><tr><td></td><td></td><td></td><td>0.52</t... |
117e64a393b7efcc8f1e579e134595db30be901b84b27c2cc83f9b3e933ba5ab.png | complex | <table><tr><td>A. Adolescents and adults</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td colspan="2"><i>Vaccination health states</i></td><td colspan="3"><i>Disease health states</i></td></tr><tr><td></td><td>Local reaction</td><td>Systemic reaction</td><td>Mild cough</td><td>Severe cough</td><td... | <table><tr><td>A. Adolescents and adults</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td colspan="2">Vaccination health states</td><td colspan="3">Disease health states</td></tr><tr><td></td><td>Local reaction</td><td>Systemic reaction</td><td>Mild cough</td><td>Severe cough</td><td>Pneumonia</td... | <table><tr><td>Mean (SD) adolescent utilities for long-term TTO (N = 81)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>0%</td><td>0.96 (0.06)</td><td>0.92 (0.09)</td><td>0.88 (0.10)</td><td>0.82 (0.13)</td><td>0.82 (0.14)</td></tr><tr><td>5%</td><td>0.97 (0.07)</td><td>0.94 (0.11)</td><td>0.91 (0.12)</t... |
58fd8001be2e18a8a4ce5d31dd911258fdbe052666dad6797f2a39cbdf6608bb.png | simple | <table><tr><td>Compound</td><td>Description</td><td>Applications</td><td>Remarks</td></tr><tr><td>In111-Capromab pendetide (ProstaScint)</td><td>A conjugation between the murine antibody 7E11.C5.3 and <sup>111</sup>Inin the source of <sup>111</sup>InCl<sub>3</sub> by the action of the GYK-DTPA as a chelating agent.</td... | <table><tr><td>Compound</td><td>Description</td><td>Applications</td><td>Remarks</td></tr><tr><td>In111-Capromab pendetide (ProstaScint)</td><td>A conjugation between the murine antibody 7E11.C5.3 and 111Inin the source of 111InCl3 by the action of the GYK-DTPA as a chelating agent.</td><td>Indicated for use in immunos... | <table><tr><td>In-111 and Y90-ibritumomab tiuxetan (Zevalin)</td><td>Zevalin consists of a murine monoclonal anti-CD20 antibody covalently conjugated to the metal chelator DTPA, which forms a stable complex with 111Infor imaging and with 90Y for therapy.</td><td>90Y-ibritumomab tiuxetan is used for the treatment of som... |
094bf483c5031052e435b64dec8ed5d5eb9d96a388ca93bc9cd95260780b6b9f.png | simple | <table><tr><td>Questions</td><td>Sub-questions</td></tr><tr><td>1. What is the first thing that comes to mind when you hear the phrase “oral health”?</td><td>a. <sup>a</sup>What does “good oral health” mean to you?i. <sup>b</sup>When you think of your child, would you say that he or she has R... | <table><tr><td>Ques</td><td>Sub-question</td></tr></table> | <table><tr><td>tions</td><td>s</td></tr><tr><td>1. What is the first thing that comes to mind when you hear the phrase “oral health”?</td><td>a. aWhat does “good oral health” mean to you?i. bWhen you think of your child, would you say that he or she has “good oral health”?ii. bHow would you describe a child who has goo... |
c4128e50eff6b2e2fbf6800852789b7b18fb486ad303f10dfa734bdf66ec98f9.png | simple | <table><tr><td>Dependent variable</td><td>Explanatory variable</td><td>Beta</td><td>Chi‐square</td><td><i>p</i> value</td><td>OR (95% confidence interval [CI])</td></tr><tr><td></td><td>Female gender</td><td>1.13</td><td>5.18</td><td>.023</td><td>3.08 (95% CI [1.17, 8.11])</td></tr><tr><td>MMP‐13 saliva</td... | <table><tr><td>Dependent variable</td><td>Explanatory variable</td><td>Beta</td><td>Chi‐square</td><td>p value</td><td>OR (95% confidence interval [CI])</td></tr><tr><td></td><td>Female gender</td><td>1.13</td><td>5.18</td><td>.023</td><td>3.08 (95% CI [1.17, 8.11])</td></tr></table> | <table><tr><td>Dependent variable</td><td>Explanatory variable</td><td>Beta</td><td>Chi‐square</td><td>p value</td><td>OR (95% confidence interval [CI])</td></tr><tr><td>MMP‐13 saliva</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>CAL</td><td>1.27</td><td>4.35</td><td>.037</td><td>3.57 (95% CI [... |
fb47b3a3693827d63e2542d4ee7b1a14eb46585f3e58b871d3f18169dc54463f.png | complex | <table><tr><td>Patient code</td><td>Age (years)</td><td>Sex</td><td>Clinical form</td><td colspan="2">Location of lesion/Code</td></tr><tr><td colspan="4"> </td><td>Cutaneous</td><td>Mucosal</td></tr><tr><td>1</td><td>52</td><td>M</td><td>MCL</td><td>Arm/1MCL-C</td><td>Oral / 1MCL-O</td></tr><tr><td>2</td><td>48</td><t... | <table><tr><td>Patient code</td><td>Age (years)</td><td>Sex</td><td>Clinical form</td><td colspan="2">Location of lesion/Code</td></tr><tr><td colspan="4"></td><td>Cutaneous</td><td>Mucosal</td></tr><tr><td>1</td><td>52</td><td>M</td><td>MCL</td><td>Arm/1MCL-C</td><td>Oral / 1MCL-O</td></tr><tr><td>2</td><td>48</td><td... | <table><tr><td>Patient code</td><td>Age (years)</td><td>Sex</td><td>Clinical form</td><td colspan="2">Location of lesion/Code</td></tr><tr><td colspan="4"></td><td>Cutaneous</td><td>Mucosal</td></tr><tr><td>18</td><td>53</td><td>M</td><td>ML</td><td>A</td><td>Nasal/18ML-N</td></tr><tr><td>19</td><td>66</td><td>F</td><t... |
0be0df9a64f01f87cda9b02feff47f61b9e5c41408160eb0a58e04c6f94b754e.png | complex | <table><tr><td></td><td>Tested population</td><td>NGO facilities</td><td>Services for migrants</td><td>DU services</td></tr><tr><td></td><td><i>N</i> = 2949 (%)</td><td><i>N</i> = 1597 (%)</td><td><i>N</i> = 928 (%)</td><td><i>N</i> = 424 (%)</td></tr><tr><td>Median age (IQR)</td><td>33 years (26–43)</td><td>31 y... | <table><tr><td></td><td>Tested population</td><td>NGO facilities</td><td>Services for migrants</td><td>DU services</td></tr><tr><td></td><td>N = 2949 (%)</td><td>N = 1597 (%)</td><td>N = 928 (%)</td><td>N = 424 (%)</td></tr><tr><td>Median age (IQR)</td><td>33 years (26–43)</td><td>31 years (25–41)</td><td>37 years (29–... | <table><tr><td></td><td>Tested population</td><td>NGO facilities</td><td>Services for migrants</td><td>DU services</td></tr><tr><td></td><td>N = 2949 (%)</td><td>N = 1597 (%)</td><td>N = 928 (%)</td><td>N = 424 (%)</td></tr><tr><td>Unknown</td><td>55 (1.9)</td><td>30 (1.9)</td><td>20 (2.2)</td><td>5 (1.2)</td></tr><tr>... |
a22f87e3f822e11bb8ecf5767b9ceeaf40b1807f7427ed3f9eb67f72b4b49e82.png | simple | <table><tr><td>Diagnosis</td><td><i>n</i></td><td>Percent</td></tr><tr><td>Small for gestational age</td><td>11</td><td>26.8</td></tr><tr><td>Disseminated intravascular coagulation</td><td>5</td><td>12.2</td></tr><tr><td>Respiratory distress syndrome</td><td>7</td><td>17.1</td></tr><tr><td>Sepsis</td><td>21</td><td>51.... | <table><tr><td>Diagnosis</td><td>n</td><td>Percent</td></tr><tr><td>Small for gestational age</td><td>11</td><td>26.8</td></tr><tr><td>Disseminated intravascular coagulation</td><td>5</td><td>12.2</td></tr><tr><td>Respiratory distress syndrome</td><td>7</td><td>17.1</td></tr><tr><td>Sepsis</td><td>21</td><td>51.2</td><... | <table><tr><td>ranial haemorrhage</td><td>1</td><td>2.4</td></tr><tr><td>Congenital heart disease</td><td>6</td><td>14.6</td></tr></table> |
5fda7661b1b2c2f18aaa21981d9bf63b7e7f6f8392e142ba9da0d58cf1d73fbf.png | complex | <table><tr><td>Gastric ulcer model</td><td>Treatments (p.o.)</td><td>Dose (g/kg)</td><td><i>n</i></td><td>Ulcer index (mm)</td><td>Inhibition (%)</td></tr><tr><td rowspan="4">Ethanol-induced</td><td>Saline</td><td>–</td><td>8</td><td>14.37 ± 2.88</td><td>–</td></tr><tr><td>Ranitidine</td><td>0.04</td><... | <table><tr><td>Gastric ulcer model</td><td>Treatments (p.o.)</td><td>Dose (g/kg)</td><td>n</td><td>Ulcer index (mm)</td></tr><tr><td rowspan="4">Ethanol-induced</td><td>Saline</td><td>–</td><td>8</td><td>14.37 ± 2.88</td></tr><tr><td>Ranitidine</td><td>0.04</td><td>8</td><td>11.27 ± 2.49∗∗</td></tr><tr><td>AIG</td><td>... | <table><tr><td>Inhibition (%)</td></tr><tr><td>–</td></tr><tr><td>29.01</td></tr><tr><td>80.43</td></tr><tr><td>71.93</td></tr><tr><td>–</td></tr><tr><td>68.68</td></tr><tr><td>75.63</td></tr><tr><td>70.33</td></tr><tr><td>–</td></tr><tr><td>64.37</td></tr><tr><td>72.49</td></tr><tr><td>63.15</td></tr></table> |
f94c6b3b3896b385eece9f86ffd5c8672f9e36f0b11f93dffa79fb980fbdc224.png | simple | <table><tr><td>Characteristics</td><td>Total <i>(n = 140)</i></td><td>TB Group <i>(n = 70)</i></td><td>Control Group <i>(n = 70)</i></td><td><i>P </i>value</td></tr><tr><td>Gender: Male</td><td>95 (68%)</td><td>56 (80%)</td><td>39 (56%)</td><td>0.002</td></tr><tr><td>Age, years, mean ± SD</td><td>35.7 ± 7.6</... | <table><tr><td>Characteristics</td><td>Total (n = 140)</td><td>TB Group (n = 70)</td><td>Control Group (n = 70)</td><td>P value</td></tr><tr><td>Gender: Male</td><td>95 (68%)</td><td>56 (80%)</td><td>39 (56%)</td><td>0.002</td></tr><tr><td>Age, years, mean ± SD</td><td>35.7 ± 7.6</td><td>34.4 ± 6.2</td><td>37.2 ± 8.7</... | <table><tr><td>Characteristics</td><td>Total (n = 140)</td><td>TB Group (n = 70)</td><td>Control Group (n = 70)</td><td>P value</td></tr><tr><td>Plasma HIV RNA, Log copies/ml, median (IQR)</td><td>5.6 (5.2–5.9)</td><td>5.7 (5.4–5.9)</td><td>5.6 (5.0–5.9)</td><td>0.004</td></tr><tr><td>ALP, mg/dl, median (IQR)</td><td>9... |
09646d2365083a3f028efa2b478645049e985d83ef8ef79235d2fa1a3669bc60.png | complex | <table><tr><td colspan="6">Most significant GO Biological Processes</td></tr><tr><td>GO Term</td><td>GO ID</td><td>Changed Genes</td><td>Total Genes in Class</td><td>P-Value</td><td>Fraction</td></tr><tr><td>Cholesterol biosynthesis</td><td>GO:0006695</td><td>12</td><td>20</td><td>7.04E-09</td><td>0.600</td></tr><tr><t... | <table><tr><td colspan="6">Most significant GO Biological Processes</td></tr><tr><td>GO Term</td><td>GO ID</td><td>Changed Genes</td><td>Total Genes in Class</td><td>P-Value</td><td>Fraction</td></tr><tr><td>Cholesterol biosynthesis</td><td>GO:0006695</td><td>12</td><td>20</td><td>7.04E-09</td><td>0.600</td></tr><tr><t... | <table><tr><td colspan="6">Most significant GO Biological Processes</td></tr><tr><td>somerase activity</td><td>GO:0016853</td><td></td><td></td><td>5.54E-04</td><td>7</td></tr><tr><td>Ligase activity</td><td>GO:0016874</td><td>27</td><td>184</td><td>5.54E-04</td><td>0.147</td></tr><tr><td>Oxidoreductase activity</td><t... |
93b6a0568ab67bdea09f45bc798579fffe9df45946324a28cd2cdd33ae11b378.png | complex | <table><tr><td>Parameters</td><td colspan="2">Vildagliptin (n-29)</td><td>P value*</td><td colspan="2">Placebo (n-29)</td><td>P value*</td><td>P value<sup>+</sup></td></tr><tr><td></td><td>Pre treatment</td><td>Post treatment</td><td></td><td>Pre-treatment</td><td>Post treatment</td></tr><tr><td>Body weight(kg)</td><td... | <table><tr><td>Parameters</td><td colspan="2">Vildagliptin (n-29)</td><td>P value*</td><td colspan="2">Placebo (n-29)</td><td>P value*</td><td>P value+</td></tr><tr><td></td><td>Pre treatment</td><td>Post treatment</td><td></td><td>Pre-treatment</td><td>Post treatment</td><td colspan="2"></td></tr></table> | <table><tr><td>Body weight(kg)</td><td>88±11.3</td><td>79±12.6</td><td>0.036</td><td>82 ±16.4</td><td>81±12.4</td><td>0.74</td><td>0.04</td></tr><tr><td>BMI(kg/m2)</td><td>30.7±4.2</td><td>27.5±5.2</td><td>0.005</td><td>29.6 ±0.4</td><td>29.4±0.7</td><td>0.88</td><td>0.028</td></tr><tr><td>TC (mg/dl)</td><td>252.6±24.4... |
380704db9284ab8defc23b6e7acb8a958af471eaf8c870f9ef8e28829c6654a3.png | simple | <table><tr><td>Feature</td><td>Control group (A)</td><td>Study group (B)</td></tr><tr><td>Number of pin-sites</td><td>268</td><td>368</td></tr><tr><td>AO tubular external fixation</td><td>43</td><td>41</td></tr><tr><td>Unilateral rail</td><td>0</td><td>2</td></tr><tr><td>Ilizarov device</td><td>6</td><td>8</td></tr><tr... | <table><tr><td>Feature</td></tr><tr><td>Number of pin-sites</td></tr><tr><td>AO tubular external fixation</td></tr><tr><td>Unilateral rail</td></tr><tr><td>Ilizarov device</td></tr><tr><td>Pin tract infection (patients)a</td></tr><tr><td>Pin tract infection (pin-sites)a</td></tr></table> | <table><tr><td>Control group (A)</td><td>Study group (B)</td></tr><tr><td>268</td><td>368</td></tr><tr><td>43</td><td>41</td></tr><tr><td>0</td><td>2</td></tr><tr><td>6</td><td>8</td></tr><tr><td>11 (22.5 %)</td><td>2 (4.1 %)</td></tr><tr><td>38 (14.2 %)</td><td>7 (1.9 %)</td></tr></table> |
6381676b6a4f28642224e4e0b695e0f88608b6726092f10efb2bd6c784f651a6.png | simple | <table><tr><td>Trials</td><td> </td><td>Intervention (<i>n</i>/<i>N</i>)</td><td>Control (<i>n</i>/<i>N</i>)</td><td>RR (95% CI)</td><td><i>P </i>value</td></tr><tr><td>LWDHW plus enalapril versus enalapril</td><td>1</td><td>34/42</td><td>21/36</td><td>3.04 (1.10, 8.38)</td><td>0.03</td></tr><tr><td>Meta-analysis</td><... | <table><tr><td>Trials</td><td></td><td>Intervention (n/N)</td><td>Control (n/N)</td><td>RR (95% CI)</td><td>P value</td></tr><tr><td>LWDHW plus enalapril versus enalapril</td><td>1</td><td>34/42</td><td>21/36</td><td>3.04 (1.10, 8.38)</td><td>0.03</td></tr></table> | <table><tr><td>Meta-analysis</td><td>1</td><td>34/42</td><td>21/36</td><td>3.04 (1.10, 8.38)</td><td>0.03</td></tr></table> |
16e67e3aaa3be8153f6dfe75c280e7d80a4e834613f55d4190f026e5012370d5.png | complex | <table><tr><td></td><td colspan="2">Non-hospitalsN = 191</td><td colspan="2">HospitalsN = 34</td><td>Chi-square (p-value)</td></tr><tr><td></td><td>Yesn (%)</td><td>Don't normally stockn (%)</td><td>Yesn (%)</td><td>Don't normally stockn (%)</td><td></td></tr><tr><td>AMT</td><td>17</td><td>18</td><td>2</td><td>13</td><... | <table><tr><td></td><td colspan="2">Non-hospitalsN = 191</td><td colspan="2">HospitalsN = 34</td><td>Chi-square (p-value)</td></tr><tr><td></td><td>Yesn (%)</td><td>Don't normally stockn (%)</td><td>Yesn (%)</td><td>Don't normally stockn (%)</td><td></td></tr><tr><td>AMT</td><td>17</td><td>18</td><td>2</td><td>13</td><... | <table><tr><td></td><td colspan="2">Non-hospitalsN = 191</td><td colspan="2">HospitalsN = 34</td><td>Chi-square (p-value)</td></tr><tr><td>Antibiotics</td><td>16</td><td>5</td><td>4</td><td>3</td><td>4.6 (.10)</td></tr><tr><td>SP</td><td>97</td><td>11</td><td>3</td><td>6</td><td>21.0 (.0001)</td></tr><tr><td>Quinine</t... |
ffe74f072a1af365443c483dc9d39e9f1c6152d70a581b6cb9802a45474b4daa.png | simple | <table><tr><td>Isolate</td><td>Collection</td><td>Country</td><td>Yr of entry into collection</td><td>Sequencing technology</td><td>Reference</td></tr><tr><td>NCTC86_Dunne</td><td>NCTC</td><td>England</td><td>1920</td><td>Pacific Biosciences RS II, Illumina</td><td>2</td></tr><tr><td>NCTC86_Meric</td><td>NCTC</td><td>E... | <table><tr><td>Isolate</td><td>Collection</td><td>Country</td><td>Yr of entry into collection</td><td>Sequencing technology</td></tr><tr><td>NCTC86_Dunne</td><td>NCTC</td><td>England</td><td>1920</td><td>Pacific Biosciences RS II, Illumina</td></tr><tr><td>NCTC86_Meric</td><td>NCTC</td><td>England</td><td>1920</td><td>... | <table><tr><td>Reference</td></tr><tr><td>2</td></tr><tr><td>4</td></tr><tr><td>This study</td></tr><tr><td>This study</td></tr><tr><td>This study</td></tr><tr><td>This study</td></tr></table> |
8fdc3e31cafeac7499b63c876a68382c69f8536d05358fe8114d06e628b98f0b.png | complex | <table><tr><td></td><td colspan="2">Placebo (<i>N </i>= 112)</td><td colspan="2">25 mg/d Neramexane (<i>N </i>= 108)</td><td colspan="2">50 mg/d Neramexane (<i>N </i>= 107)</td><td colspan="2">75 mg/d Neramexane (<i>N </i>= 102)</td></tr><tr><td></td><td><i>n</i></td><td>%</td><td><i>n</i></td><td>%</td><td><i>n</i></t... | <table><tr><td></td><td colspan="2">Placebo (N = 112)</td><td colspan="2">25 mg/d Neramexane (N = 108)</td><td colspan="2">50 mg/d Neramexane (N = 107)</td><td colspan="2">75 mg/d Neramexane (N = 102)</td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr></table> | <table><tr><td>Any adverse event</td><td>4</td><td>3.6</td><td>7</td><td>6.5</td><td>9</td><td>8.4</td><td>21</td><td>20.6</td></tr><tr><td>Dizziness</td><td>1</td><td>0.9</td><td>2</td><td>1.9</td><td>7</td><td>6.5</td><td>15</td><td>14.7</td></tr><tr><td>Vertigo</td><td>0</td><td>0.0</td><td>1</td><td>0.9</td><td>2</... |
e1f84b58e16d4ed114576f2274a11efc48770c7a3b7f22b5acb889cb8119d05d.png | complex | <table><tr><td colspan="6">Prevalence of elevated CRP (>10 mg/L)</td></tr><tr><td>Group</td><td></td><td>%</td><td>Univariate p-value</td><td>Multivariate OR *</td><td>Multivariate p-value**</td></tr><tr><td>Age</td><td><50</td><td>14</td><td>0.49</td><td></td><td></td></tr><tr><td></td><td>50–59</td><td>13... | <table><tr><td colspan="4">Prevalence of elevated CRP (>10 mg/L)</td></tr><tr><td>Group</td><td></td><td>%</td><td>Univariate p-value</td></tr><tr><td>Age</td><td><50</td><td>14</td><td>0.49</td></tr><tr><td></td><td>50–59</td><td>13</td><td></td></tr><tr><td></td><td>60–69</td><td>13</td><td></td></tr><tr><td></td><td... | <table><tr><td colspan="2">Prevalence of elevated CRP (>10 mg/L)</td></tr><tr><td>Multivariate OR *</td><td>Multivariate p-value**</td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td>(ref)</td>... |
f9b1af56ad42e58079a2ac526a9004f8e369c969ab59730d6ad6aa68b3c7bf3d.png | complex | <table><tr><td> </td><td colspan="2">Insular cortex</td><td rowspan="2">Posterior cingulate cortex</td></tr><tr><td> </td><td>Right</td><td>Left</td></tr><tr><td>No. of participants</td><td>4</td><td>4</td><td>4</td></tr><tr><td>Peak latency (ms)</td><td>191.0 ± 10.6</td><td>184.0 ± 4.6</td><td>468.0 ± 1... | <table><tr><td></td><td colspan="2">Insular cortex</td><td rowspan="2">Posterior cingulate cortex</td></tr><tr><td></td><td>Right</td><td>Left</td></tr><tr><td>No. of participants</td><td>4</td><td>4</td><td>4</td></tr><tr><td>Peak latency (ms)</td><td>191.0 ± 10.6</td><td>184.0 ± 4.6</td><td>468.0 ± 13.5</td></tr></ta... | <table><tr><td>GOF (%)</td><td>95.3 ± 2.1</td><td>93.5 ± 1.6</td><td>95.8 ± 1.5</td></tr><tr><td>Intensity (nA · m)</td><td>25.0 ± 2.8</td><td>16.7 ± 2.5</td><td>16.4 ± 3.3</td></tr><tr><td>Locations*</td><td></td><td></td><td></td></tr><tr><td>x (mm)</td><td>41.8 ± 2.7</td><td>−41.7 ± 3.1</td><td>−8.3 ± 2.6</td></tr><... |
12372347dd4830ec385018ef16b672975711a9e7d552437ad880f5300715b3f7.png | simple | <table><tr><td></td><td>Males (n = 196)</td><td>Females (n = 210)</td><td>Total (n = 406)</td></tr><tr><td>Career aspiration</td><td>Mean (SD)</td><td>Mean (SD)</td><td>Mean (SD)</td></tr><tr><td>Private practice (n = 192)</td><td>1.18 (1.44)</td><td>0.61 (0.98)</td><td>0.84 (1.22)</td></tr><tr><td>Hospital career (n =... | <table><tr><td></td><td>Males (n = 196)</td><td>Females (n = 210)</td><td>Total (n = 406)</td></tr><tr><td>Career aspiration</td><td>Mean (SD)</td><td>Mean (SD)</td><td>Mean (SD)</td></tr><tr><td>Private practice (n = 192)</td><td>1.18 (1.44)</td><td>0.61 (0.98)</td><td>0.84 (1.22)</td></tr><tr><td>Hospital career (n =... | <table><tr><td></td><td>Males (n = 196)</td><td>Females (n = 210)</td><td>Total (n = 406)</td></tr><tr><td>Career aspiration</td><td>Mean (SD)</td><td>Mean (SD)</td><td>Mean (SD)</td></tr><tr><td>Effect</td><td>F</td><td>P</td><td>Partial eta squared</td></tr><tr><td>Gender</td><td>F(1,400) = 21.77</td><td>0.001</td><t... |
5398953270c4d87f2c9931e2d94a3ae6a987028ff05c6c0aaa16dbcca2a4c66d.png | simple | <table><tr><td></td><td>Odds ratio</td><td>95% Confidentialinterval</td><td><i>P</i>-value</td></tr><tr><td>Laboratory variables</td><td></td><td></td><td></td></tr><tr><td>Gamma-glutamyltranspeptidase, IU/L</td><td>1.009</td><td>0.953, 1.068</td><td>0.757</td></tr><tr><td>Cumulative dose of medications, mg</td><td></t... | <table><tr><td></td><td>Odds ratio</td><td>95% Confidentialinterval</td><td>P-value</td></tr><tr><td>Laboratory variables</td><td></td><td></td><td></td></tr><tr><td>Gamma-glutamyltranspeptidase, IU/L</td><td>1.009</td><td>0.953, 1.068</td><td>0.757</td></tr></table> | <table><tr><td></td><td>Odds ratio</td><td>95% Confidentialinterval</td><td>P-value</td></tr><tr><td>Cumulative dose of medications, mg</td><td></td><td></td><td></td></tr><tr><td>Leflunomide (53 patients)</td><td>1.000</td><td>1.000, 1.000</td><td>0.007</td></tr><tr><td>Prednisolone (89 patients)</td><td>1.000</td><td... |
618c16b01d28d2472741ae491f4bd5b2482cce3c2ca86f8cc8ca1d4f730afc27.png | simple | <table><tr><td>Clinical presentatiton</td><td>No. of patients</td><td>No. of episods</td><td>Time* (median/month)</td><td>Treatment</td></tr><tr><td>Cholangitis</td><td>5</td><td>9</td><td>19.5 (14–47)</td><td>Medical</td></tr><tr><td> -without real stricture</td><td>3</td><td>3</td><td>28.3</td><td>Medical</td><... | <table><tr><td>Clinical present</td><td>No. of patien</td><td>No. of episods</td><td>Time* (median/month</td><td>Treatme</td></tr></table> | <table><tr><td>atiton</td><td>ts</td><td></td><td>)</td><td>nt</td></tr><tr><td>Cholangitis</td><td>5</td><td>9</td><td>19.5 (14–47)</td><td>Medical</td></tr><tr><td>-without real stricture</td><td>3</td><td>3</td><td>28.3</td><td>Medical</td></tr><tr><td>-with real stricture</td><td>2</td><td>6</td><td>15.5</td><td>En... |
f4468aef0d2094bef50b01cd4d4737674626fb82c87e5d1a6b0f8f83310754f1.png | complex | <table><tr><td> </td><td colspan="5">Awareness of ESCCAP Heartworm Guidelines</td><td> </td></tr><tr><td> </td><td colspan="5">Number clinics responding (% responding)</td><td> </td></tr><tr><td>Country</td><td>Not aware</td><td>Slightly aware</td><td>Moderately aware</td><td>Quite aware</td><td>Very aware</td><td>Resp... | <table><tr><td></td><td colspan="5">Awareness of ESCCAP Heartworm Guidelines</td><td></td></tr><tr><td></td><td colspan="5">Number clinics responding (% responding)</td><td></td></tr><tr><td>Country</td><td>Not aware</td><td>Slightly aware</td><td>Moderately aware</td><td>Quite aware</td><td>Very aware</td><td>Responde... | <table><tr><td></td><td colspan="5">Awareness of ESCCAP Heartworm Guidelines</td><td></td></tr><tr><td></td><td colspan="5">Number clinics responding (% responding)</td><td></td></tr><tr><td>Country</td><td>Not aware</td><td>Slightly aware</td><td>Moderately aware</td><td>Quite aware</td><td>Very aware</td><td>Responde... |
cdd86b7310d60f3433a4ee4a12383e6c5d2c7085adbaa542dd0086b9768e281f.png | simple | <table><tr><td>Type of model or algorithm</td><td>Target product</td><td>Model-based target: knockout gene A or overexpress gene B</td><td>References</td></tr><tr><td>Dynamic flux balance analysis</td><td>Ethanol</td><td>Ethanol production pathway after 20 h</td><td>[163]</td></tr><tr><td>Genome-scale metabolic model</... | <table><tr><td>Type of model or algorithm</td><td>Target product</td><td>Model-based target: knockout gene A or overexpress gene B</td><td>References</td></tr><tr><td>Dynamic flux balance analysis</td><td>Ethanol</td><td>Ethanol production pathway after 20 h</td><td>[163]</td></tr><tr><td>Genome-scale metabolic model</... | <table><tr><td>Type of model or algorithm</td><td>Target product</td><td>Model-based target: knockout gene A or overexpress gene B</td><td>References</td></tr><tr><td>Metabolic flux analysis</td><td>Astaxanthin synthesis</td><td>–</td><td>[167]</td></tr><tr><td>Metabolic flux analysis</td><td>Fixed more CO2 and had a h... |
fad23e29abf6cdc4ffe204b801328adc3cafc93637dbb245b0e76639af474f88.png | complex | <table><tr><td colspan="2">Severity of stress</td></tr><tr><td><i>n</i> = 85</td><td>%</td></tr><tr><td>Severe</td><td>33</td></tr><tr><td>Moderate</td><td>27</td></tr><tr><td>Extreme</td><td>22</td></tr><tr><td>None/light</td><td>8</td></tr><tr><td>Catastrophic</td><td>6</td></tr></table> | <table><tr><td>Severity of stress</td></tr><tr><td>n = 85</td></tr><tr><td>Severe</td></tr><tr><td>Moderate</td></tr><tr><td>Extreme</td></tr><tr><td>None/light</td></tr><tr><td>Catastrophic</td></tr></table> | <table><tr><td>Severity of stress</td></tr><tr><td>%</td></tr><tr><td>33</td></tr><tr><td>27</td></tr><tr><td>22</td></tr><tr><td>8</td></tr><tr><td>6</td></tr></table> |
3083d5f0ce0722431af6d04c1bc0e68b248c0f818055bff9e2770c2759277424.png | complex | <table><tr><td colspan="2"> </td><td><i>N</i></td><td>%</td><td>Age (mean ± SD)</td></tr><tr><td rowspan="2">Sex</td><td>Male</td><td>50</td><td>54.0%</td><td rowspan="2">39.60 ± 7.32</td></tr><tr><td>Female</td><td>40</td><td>46.0%</td></tr></table> | <table><tr><td colspan="2"></td><td>N</td><td>%</td><td>Age (mean ± SD)</td></tr></table> | <table><tr><td rowspan="2">Sex</td><td>Male</td><td>50</td><td>54.0%</td><td rowspan="2">39.60 ± 7.32</td></tr><tr><td>Female</td><td>40</td><td>46.0%</td></tr></table> |
c0003d710a380e3f0be04b76e5a38166bbafa883e1fa7839667c3510290c2410.png | complex | <table><tr><td> </td><td colspan="6">Any first-degree relative</td></tr><tr><td> </td><td colspan="3">History of cancer (any site)</td><td colspan="3">History of head and neck cancer</td></tr><tr><td> </td><td><sup>‡</sup>No</td><td>Yes</td><td>OR (95% CI)<sup>†</sup></td><td><sup>§</sup>No</td><td>Yes... | <table><tr><td></td><td colspan="6">Any first-degree relative</td></tr><tr><td></td><td colspan="3">History of cancer (any site)</td><td colspan="3">History of head and neck cancer</td></tr><tr><td></td><td>‡No</td><td>Yes</td><td>OR (95% CI)†</td><td>§No</td><td>Yes</td><td>OR (95% CI)†</td></tr><tr><td></td><td>Cases... | <table><tr><td>≤2 glasses/day</td><td>75/961</td><td>75/954</td><td>0.9 (0.6-1.4)</td><td>123/1704</td><td>11/88</td><td>1.9 (1.0-3.5)</td></tr><tr><td>>2 glasses/day</td><td>167/597</td><td>254/631</td><td>1.4 (1.0-1.8)</td><td>329/1066</td><td>52/67</td><td>2.6 (1.2-3.3)</td></tr><tr><td colspan="2">Smoking & drinkin... |
c5e9f5e53084f43e43157bbb2a3214b82d5b18ed96eb8b55675c289a2b50134f.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="3">Univariate analysis</td><td colspan="3">Multivariate analysis</td></tr><tr><td>HR</td><td>95% CI</td><td><i>P</i> value</td><td>HR</td><td>95% CI</td><td><i>P</i> value</td></tr><tr><td>Sex (Female, Male)</td><td>1.2533</td><td>0.7767-2.0222</td><td>0.3550</td><td... | <table><tr><td rowspan="2">Variable</td><td colspan="2">Univariate analysis</td></tr><tr><td>HR</td><td>95% CI</td></tr><tr><td>Sex (Female, Male)</td><td>1.2533</td><td>0.7767-2.0222</td></tr><tr><td>Age (≤ 60, > 60)</td><td>0.6990</td><td>0.4635-1.0542</td></tr><tr><td>Macroscopic types (Ul, Fu, Me)</td><td>1.0699</t... | <table><tr><td>Univariate analysis</td><td colspan="3">Multivariate analysis</td></tr><tr><td>P value</td><td>HR</td><td>95% CI</td><td>P value</td></tr><tr><td>0.3550</td><td colspan="3"></td></tr><tr><td>0.0876</td><td colspan="3"></td></tr><tr><td>0.6912</td><td colspan="3"></td></tr><tr><td>0.7061</td><td colspan="... |
b3b07a886640a8b58e68ae35592f1e922b79e67902cad97fdee399bf49fac84d.png | complex | <table><tr><td></td><td colspan="2">Pre-VT SC-IAT</td><td colspan="2">Embodiment after first session of VT</td><td colspan="2">Embodiment after second session of VT</td><td colspan="2">Post-VT SC-IAT</td></tr><tr><td></td><td><i>M</i></td><td>SD</td><td><i>M</i></td><td>SD</td><td><i>M</i></td><td>SD</td><td><i>M</i></... | <table><tr><td></td><td colspan="2">Pre-VT SC-IAT</td><td colspan="2">Embodiment after first session of VT</td><td colspan="2">Embodiment after second session of VT</td><td colspan="2">Post-VT SC-IAT</td></tr><tr><td></td><td>M</td><td>SD</td><td>M</td><td>SD</td><td>M</td><td>SD</td><td>M</td><td>SD</td></tr><tr><td>S... | <table><tr><td></td><td colspan="2">Pre-VT SC-IAT</td><td colspan="2">Embodiment after first session of VT</td><td colspan="2">Embodiment after second session of VT</td><td colspan="2">Post-VT SC-IAT</td></tr><tr><td></td><td>M</td><td>SD</td><td>M</td><td>SD</td><td>M</td><td>SD</td><td>M</td><td>SD</td></tr><tr><td>S... |
73d2272368e805637c8c419454b12ec6b3d9752b8df7b76997ce03bd57032097.png | complex | <table><tr><td rowspan="3">Group</td><td rowspan="3">n</td><td rowspan="3">Age (year)</td><td rowspan="3">Infertility duration (year)</td><td rowspan="3">BMI</td><td colspan="4">Reproductive hormone level</td></tr><tr><td>FSH/IU·L<sup>-1</sup></td><td>LH/IU·L<sup>-1</sup></td><td>E2/pg·mL<sup>-1</sup></t... | <table><tr><td rowspan="3">Group</td><td rowspan="3">n</td><td rowspan="3">Age (year)</td><td rowspan="3">Infertility duration (year)</td><td rowspan="3">BMI</td><td colspan="4">Reproductive hormone level</td></tr><tr><td>FSH/IU·L-1</td><td>LH/IU·L-1</td><td>E2/pg·mL-1</td><td>T/mmol·L-1</td></tr><tr><td colspan="4"></... | <table><tr><td rowspan="3">Group</td><td rowspan="3">n</td><td rowspan="3">Age (year)</td><td rowspan="3">Infertility duration (year)</td><td rowspan="3">BMI</td><td colspan="4">Reproductive hormone level</td></tr><tr><td>FSH/IU·L-1</td><td>LH/IU·L-1</td><td>E2/pg·mL-1</td><td>T/mmol·L-1</td></tr><tr><td colspan="4"></... |
42e3dae8597b8ff4119c06b0fa9007c1381c0894148373c0903d60356aa3643b.png | simple | <table><tr><td></td><td>Input type</td><td>Database update</td><td>Functional Database support</td><td>Multiple organism support</td><td>Limitations for input genes</td><td>Statistics</td></tr><tr><td>GeneSCF v1.1</td><td>List of genes</td><td>Real-time</td><td>KEGG, GO, Reactome and NCG</td><td>Yes</td><td>No upper or... | <table><tr><td></td><td>Input type</td><td>Database update</td><td>Functional Database support</td><td>Multiple organism support</td><td>Limitations for input genes</td><td>Statistics</td></tr><tr><td>GeneSCF v</td><td>List of g</td><td>R</td><td>KEGG, GO, Reactome a</td><td></td><td>No upper or lower</td><td>FE </td><... | <table><tr><td>1.1</td><td>enes</td><td>eal-time</td><td>nd NCG</td><td>Yes</td><td> limit</td><td>test a & FDR b</td></tr><tr><td>GeneSCF v1.0</td><td>List of genes</td><td>Manual (preparation needed)</td><td>KEGG, GO, Reactome and NCG</td><td>No (Homo sapiens)</td><td>No upper or lower limit</td><td>FE test & FDR</td... |
fb4326c5de8dcb7a40b870d7d2d857a601e0fa96bc0623091e22c74843293daa.png | complex | <table><tr><td>DHFR</td><td colspan="5">Regions (%)</td><td>Total N (%)</td></tr><tr><td>Repeat Type</td><td>Delhi</td><td>Nadiad</td><td>Panna</td><td>Chennai</td><td>Kamrup</td><td></td></tr><tr><td>Type 1</td><td>54.54</td><td>0</td><td>11.76</td><td>0</td><td>0</td><td>8 (11.26)</td></tr><tr><td>Type 2</td><td>36.3... | <table><tr><td>DHFR</td><td colspan="5">Regions (%)</td><td>Total N (%)</td></tr><tr><td>Repeat Type</td><td>Delhi</td><td>Nadiad</td><td>Panna</td><td>Chennai</td><td>Kamrup</td><td></td></tr><tr><td>Type 1</td><td>54.54</td><td>0</td><td>11.76</td><td>0</td><td>0</td><td>8 (11.26)</td></tr><tr><td>Type 2</td><td>36.3... | <table><tr><td>DHFR</td><td colspan="5">Regions (%)</td><td>Total N (%)</td></tr><tr><td>Repeat Type</td><td>Delhi</td><td>Nadiad</td><td>Panna</td><td>Chennai</td><td>Kamrup</td><td></td></tr><tr><td>Total (N)</td><td>20</td><td>20</td><td>18*</td><td>20</td><td>19*</td><td>97</td></tr></table> |
7239276a48784427fd77c047178a18e8bec860617499717089cdaf0d34cfa400.png | simple | <table><tr><td>Items</td><td>Cronbach’s alpha if items were deleted</td></tr><tr><td>Physical functioning</td><td>0.845</td></tr><tr><td>Mental health</td><td>0.847</td></tr><tr><td>Vitality</td><td>0.849</td></tr><tr><td>Role physical</td><td>0.858</td></tr><tr><td>General health</td><td>0.853</td></tr><tr><td>B... | <table><tr><td>Items</td></tr><tr><td>Physical functioning</td></tr><tr><td>Mental health</td></tr><tr><td>Vitality</td></tr><tr><td>Role physical</td></tr><tr><td>General health</td></tr><tr><td>Bodily pain</td></tr><tr><td>Role emotional</td></tr><tr><td>Social functioning</td></tr><tr><td>Educational rescue policy</... | <table><tr><td>Cronbach’s alpha if items were deleted</td></tr><tr><td>0.845</td></tr><tr><td>0.847</td></tr><tr><td>0.849</td></tr><tr><td>0.858</td></tr><tr><td>0.853</td></tr><tr><td>0.857</td></tr><tr><td>0.862</td></tr><tr><td>0.856</td></tr><tr><td>0.871</td></tr><tr><td>0.871</td></tr><tr><td>0.871</td></tr><tr>... |
c18afd04261552ab10312747cee2a43ae0fe83363f72c79a0c45e72f051ee565.png | simple | <table><tr><td>Crude extract<sup>a</sup></td><td>Yield<sup>b</sup>(g)</td><td>Yield<sup>c</sup>(% of pollen sample)</td><td>Appearance</td></tr><tr><td><i>Corn bee pollen extracts</i></td><td> </td><td> </td><td> </td></tr><tr><td>CMEb</td><td>35.29</td><td>8.40</td><td>Dark brown sticky solid</td></tr><tr><td>CDEb</td... | <table><tr><td>Crude extracta</td><td>Yieldb(g)</td><td>Yieldc(% of pollen sample)</td><td>Appearance</td></tr><tr><td>Corn bee pollen extracts</td><td></td><td></td><td></td></tr><tr><td>CMEb</td><td>35.29</td><td>8.40</td><td>Dark brown sticky solid</td></tr><tr><td>CDEb</td><td>2.40</td><td>0.57</td><td>Dark brown s... | <table><tr><td>Crude extracta</td><td>Yieldb(g)</td><td>Yieldc(% of pollen sample)</td><td>Appearance</td></tr><tr><td>CMEp</td><td>9.02</td><td>2.15</td><td>Dark brown solid</td></tr><tr><td>CDEp</td><td>4.82</td><td>1.15</td><td>Brown solid</td></tr><tr><td>CHEp</td><td>7.87</td><td>1.87</td><td>Dark green oil/wax</t... |
190cc89e660dfa4f641ab5861e88e9a0e80418d4f3a1f2c2f1eb6a9c7a9b02c5.png | complex | <table><tr><td>The Job stress Survey (JSS) Items</td><td>Lack of support leaders</td><td>Demanding job tasks</td><td>Time pressure</td><td>Lack of support co-workers</td></tr><tr><td>No participating in decisions</td><td>0.84</td><td><i>0.20</i></td><td><i>0.03</i></td><td><i>0.04</i></td></tr><tr><td>Lack recognition ... | <table><tr><td>The Job stress Survey (JSS) Items</td><td>Lack of support leaders</td><td>Demanding job tasks</td><td>Time pressure</td><td>Lack of support co-workers</td></tr><tr><td>No participating in decisions</td><td>0.84</td><td>0.20</td><td>0.03</td><td>0.04</td></tr><tr><td>Lack recognition for good work</td><td... | <table><tr><td>riance</td><td>4</td><td></td><td></td><td>0</td></tr><tr><td colspan="2">The Norwegian Ambulance Stress Survey (NASS)</td><td>Non-Emergency tasks</td><td>Serious operational tasks</td><td>Physical demands</td></tr><tr><td>Hide feelings towards patients and relatives</td><td></td><td>0.83</td><td>0.13</t... |
e97e56c55386a325297274d2706a9fa01c62ef42e4e6a962e6da8dcbf959dadc.png | complex | <table><tr><td></td><td>English 1st Language</td><td>N</td><td>Mean</td><td>SD</td><td>Age</td><td>N</td><td>Mean</td><td>SD</td><td>Student</td><td>N</td><td>Mean</td><td>SD</td></tr><tr><td rowspan="2">Sum 18 Item</td><td>Yes</td><td>229</td><td>37.96</td><td>7.72</td><td>Younger</td><td>133</td><td>38.56</td><td>7.6... | <table><tr><td></td><td>English 1st Language</td><td>N</td><td>Mean</td><td>SD</td><td>Age</td><td>N</td><td>Mean</td><td>SD</td><td>Student</td><td>N</td><td>Mean</td><td>SD</td></tr><tr><td rowspan="2">Sum 18 Item</td><td>Yes</td><td>229</td><td>37.96</td><td>7.72</td><td>Younger</td><td>133</td><td>38.56</td><td>7.6... | <table><tr><td>Sum EQ</td><td>No</td><td>29</td><td>19.28</td><td>5.85</td><td>Older</td><td>119</td><td>16.71*</td><td>6.05</td><td>No</td><td>141</td><td>17.73</td><td>5.68</td></tr></table> |
768489888c11bc3bce26d86ba71a9f0944166ef169145243c0111e948f4ba6e5.png | simple | <table><tr><td>Cut-off</td><td>No of studies</td><td>Co-sensitivity (95 % CI)</td><td>Co-specificity (95 % CI)</td><td>I<sup>2</sup> (95%CI)</td><td>Pooled positive LR</td><td>Pooled negative LR</td></tr><tr><td>1.5 cm</td><td>1</td><td>0.93</td><td>0.16</td><td>–</td><td>1.1</td><td>0.43</td></tr><tr><td>2 cm</t... | <table><tr><td>Cut-off</td><td>No of studies</td><td>Co-sensitivity (95 % CI)</td><td>Co-specificity (95 % CI)</td><td>I2 (95%CI)</td><td>Pooled positive LR</td><td>Pooled negative LR</td></tr><tr><td>1.5 cm</td><td>1</td><td>0.93</td><td>0.16</td><td>–</td><td>1.1</td><td>0.43</td></tr><tr><td></td><td>2</td><td>0.</t... | <table><tr><td>2 cm</td><td></td><td>95, 1</td><td>, 0.20</td><td>–</td><td>.25</td><td>0</td></tr><tr><td>2.5 cm</td><td>3</td><td>0.79, 1, 0.84</td><td>0.84, 0.58, 0.66</td><td>–</td><td>4.93, 2.38, 2.47</td><td>0.25, 0, 0.24</td></tr><tr><td>3 cm</td><td>7</td><td>0.83, (0.56–0.95)</td><td>0.64, (0.45–0.79)</td><td>... |
4a457cdd517762d49279d19b5e77dae518b03ed67ae52dcc5668b61a67fcb8f2.png | simple | <table><tr><td> </td><td>Men</td><td>Women</td><td>p-value*</td></tr><tr><td>Number of patients</td><td>289</td><td>284</td><td> </td></tr><tr><td>Number of deaths</td><td>41</td><td>21</td><td> </td></tr><tr><td>Number of admissions</td><td>1924</td><td>3139</td><td> </td></tr><tr><td>Total time of follow-up (person-y... | <table><tr><td></td><td></td><td></td><td>p-valu</td></tr></table> | <table><tr><td></td><td>Men</td><td>Women</td><td>e*</td></tr><tr><td>Number of patients</td><td>289</td><td>284</td><td></td></tr><tr><td>Number of deaths</td><td>41</td><td>21</td><td></td></tr><tr><td>Number of admissions</td><td>1924</td><td>3139</td><td></td></tr><tr><td>Total time of follow-up (person-years)</td>... |
a456d971532e7deb33a4a068b6ccc6ac85b538fdd784f444a8ac6aaa725493de.png | complex | <table><tr><td colspan="2">PBMS</td><td colspan="3">DMT status</td><td colspan="2"> </td></tr><tr><td colspan="2">Domains</td><td>pre-test</td><td>RCT</td><td>pos-</td><td colspan="2">p-value</td></tr><tr><td> </td><td>Sub-domains</td><td>without /with</td><td>without /with</td><td>sible range</td><td>pre</td><td>RCT</... | <table><tr><td colspan="2">PBMS</td><td colspan="3">DMT status</td><td colspan="2"></td></tr><tr><td colspan="2">Domains</td><td>pre-test</td><td>RCT</td><td>pos-</td><td colspan="2">p-value</td></tr><tr><td></td><td></td><td></td><td>without /w</td><td></td><td>pr</td><td>RCT</td></tr></table> | <table><tr><td></td><td>Sub-domains</td><td>without /with</td><td>ith</td><td>sible range</td><td>e</td><td></td></tr><tr><td colspan="2">1: Attitude</td><td>2.1 / 4.6</td><td>2.4 / 4.1</td><td>0-9</td><td><.01</td><td><.01</td></tr><tr><td></td><td>a: expectations regarding outcomes</td><td>1.4 / 2.0</td><td>1.5 / 1.9... |
951d0c0551bc13f9e7483fefd1b901b0e6ed8a9ffbbd07f1772e02c06752c2a5.png | simple | <table><tr><td>SNP</td><td>Position</td><td>Alleles<sup>†</sup></td><td>MAF</td><td>Beta</td><td>s.e.</td><td><i>P</i></td><td><i>P</i><sub><i>emp</i></sub></td></tr><tr><td>rs1333049</td><td>22,115,503</td><td>C/G</td><td>0.421</td><td>0.0119</td><td>0.012</td><td>3.45E-01</td><td>3.44E-01</td></tr></table> | <table><tr><td>SNP</td><td>Position</td><td>Alleles†</td><td>MAF</td><td>Beta</td><td>s.e.</td><td>P</td><td>Pemp</td></tr></table> | <table><tr><td>rs1333049</td><td>22,115,503</td><td>C/G</td><td>0.421</td><td>0.0119</td><td>0.012</td><td>3.45E-01</td><td>3.44E-01</td></tr></table> |
60c70fcd5d96f7d3fbd7a86998713df099ed8c97a4d471bcf4ef8c48435b0b5d.png | simple | <table><tr><td>Characteristics</td><td>Yes (%)</td><td>No (%)</td></tr><tr><td>Ever received an introduction into work place ergonomics</td><td>24 (14.7%)</td><td>136 (83.4%)</td></tr><tr><td>Ever experienced work-related musculoskeletal problems</td><td>123 (75.5%)</td><td>40 (24.5%)</td></tr><tr><td>Musculoskeletal p... | <table><tr><td>Characteristics</td><td>Yes (%)</td><td>No (%)</td></tr><tr><td>Ever received an introduction into work place ergonomics</td><td>24 (14.7%)</td><td>136 (83.4%)</td></tr><tr><td>Ever experienced work-related musculoskeletal problems</td><td>123 (75.5%)</td><td>40 (24.5%)</td></tr><tr><td>Musculoskeletal p... | <table><tr><td>Ever experienced occupational injuries in pathology</td><td>135 (82.8%)</td><td>28 (17.2%)</td></tr><tr><td>Experienced such injuries in the last year (n=135)</td><td>37 (27.4%)</td><td>95 (70.4%)</td></tr><tr><td>Remaining permanent damages from such injuries (n=135)</td><td>5 (3.7%)</td><td>127 (94.1%)... |
a8dd9ca21cebccbb1c9f3642fc8a95e33a972dffe40c5f20b6d7e0bf6cfa8cb2.png | simple | <table><tr><td>Method Label</td><td>Method Description</td><td>Library used within R statistical software</td><td>Number of iterations</td></tr><tr><td>CC</td><td>Complete case analysis: Analyses only cases with complete data for all covariates</td><td></td><td>-</td></tr><tr><td>SI</td><td>Single imputation performed ... | <table><tr><td>Method Label</td><td>Method Description</td><td>Library used within R statistical software</td><td>Number of iterations</td></tr><tr><td>CC</td><td>Complete case analysis: Analyses only cases with complete data for all covariates</td><td></td><td>-</td></tr><tr><td>SI</td><td>Single imputation performed ... | <table><tr><td>MI-NORM</td><td>Multiple imputation (MI) using data augmentation approach [31] with a multivariate normal assumption for all variables</td><td>'norm' [41]</td><td>100</td></tr><tr><td>MI-MIX</td><td>MI using data augmentation approach using a general location model</td><td>'mix' [42]</td><td>100</td></tr... |
74c4216008f360e0cafe5770b3497d4b343537f94c6189aa159773f00a3e5bb9.png | simple | <table><tr><td>Case No.</td><td>Age(yrs)</td><td>FIGO score</td><td>AP</td><td>Interval time (mons)</td><td>Pretreatment serum β-hCG level</td><td>Site of metastases</td><td>Chemotherapy</td><td>Cause of death</td></tr><tr><td>1</td><td>53</td><td>15</td><td>Abortion</td><td>180</td><td>99000.0</td><td>Lung/brain/... | <table><tr><td>Case No.</td><td>Age(yrs)</td><td>FIGO score</td><td>AP</td><td>Interval time (mons)</td><td>Pretreatment serum β-hCG level</td></tr><tr><td>1</td><td>53</td><td>15</td><td>Abortion</td><td>180</td><td>99000.0</td></tr><tr><td>2</td><td>30</td><td>21</td><td>Abortion</td><td>10</td><td>906720.0</td></tr>... | <table><tr><td>Site of metastases</td><td>Chemotherapy</td><td>Cause of death</td></tr><tr><td>Lung/brain/kidney</td><td>Not done</td><td>Brain hemorrhage, respiratory failure</td></tr><tr><td>Lung/brain/liver/kidney</td><td>Not done</td><td>Septic shock</td></tr><tr><td>Lung/brain</td><td>5-FU*1d</td><td>Brain herniat... |
52c058b55cf7c34f33340fec7030b4d9688c7244376dc96309fb1119638ebaf1.png | complex | <table><tr><td>Characteristics</td><td colspan="2">Antenatal care utilization (< 4 times and ≥ 4 times)</td></tr><tr><td> </td><td>BivariateOR (95% CI)</td><td>MultivariateOR (95% CI)</td></tr><tr><td>Education</td><td> </td><td> </td></tr><tr><td>Illiterate</td><td>1</td><td>1</td></tr><tr><td>Informal educat... | <table><tr><td>Characteristics</td><td colspan="2">Antenatal care utilization (< 4 times and ≥ 4 times)</td></tr><tr><td></td><td>BivariateOR (95% CI)</td><td>MultivariateOR (95% CI)</td></tr><tr><td>Education</td><td></td><td></td></tr><tr><td>Illiterate</td><td>1</td><td>1</td></tr><tr><td>Informal education</td><td>... | <table><tr><td>Characteristics</td><td colspan="2">Antenatal care utilization (< 4 times and ≥ 4 times)</td></tr><tr><td></td><td>BivariateOR (95% CI)</td><td>MultivariateOR (95% CI)</td></tr><tr><td colspan="3">Distance to health facility</td></tr><tr><td>> 30 min</td><td>1</td><td>1</td></tr><tr><td>≤ 30 min</td><td>... |
7e1855cc3d23779a41a0ec72a82983ccd4112614e35f51876ef1115337ac1f73.png | simple | <table><tr><td>Organism</td><td>BlastX threshold</td><td>Matches against 454 unigenes</td><td>Matches against Sanger unigenes</td></tr><tr><td><i>Arabidopsis </i>(31,921)</td><td>1e-5</td><td>14250 (45%)</td><td>10154 (32%)</td></tr><tr><td></td><td>1e-10</td><td>12347 (39%)</td><td>9561 (30%)</td></tr><tr><td></td><td... | <table><tr><td>Organism</td><td>BlastX threshold</td></tr><tr><td>Arabidopsis (31,921)</td><td>1e-5</td></tr><tr><td></td><td>1e-10</td></tr><tr><td></td><td>1e-20</td></tr><tr><td>Arabidopsis with transcript evidence (22,032)</td><td>1e-5</td></tr><tr><td></td><td>1e-10</td></tr><tr><td></td><td>1e-20</td></tr><tr><td... | <table><tr><td>Matches against 454 unigenes</td><td>Matches against Sanger unigenes</td></tr><tr><td>14250 (45%)</td><td>10154 (32%)</td></tr><tr><td>12347 (39%)</td><td>9561 (30%)</td></tr><tr><td>9077 (28%)</td><td>8410 (26%)</td></tr><tr><td>12790 (58%)</td><td>9542 (43%)</td></tr><tr><td>11265 (51%)</td><td>9029 (4... |
737c9398bd5825a4458d22d7b4d593d1e69a37b7599cf779eebea314610153de.png | simple | <table><tr><td>DATA CATEGORY</td><td>DATA</td></tr><tr><td>Counter IDIN</td><td>37–95</td></tr><tr><td>Station </td><td>95</td></tr><tr><td>County</td><td>37</td></tr><tr><td>City</td><td>35</td></tr><tr><td>Route</td><td>65</td></tr><tr><td>Mile point</td><td>250.08</td></tr><tr><td>AADT 2009</td><td>115,150</td... | <table><tr><td>DATA CATEGORY</td></tr><tr><td>Counter IDIN</td></tr><tr><td>Station</td></tr><tr><td>County</td></tr><tr><td>City</td></tr><tr><td>Route</td></tr><tr><td>Mile point</td></tr><tr><td>AADT 2009</td></tr><tr><td>AADT 2008</td></tr><tr><td>AADT 2007</td></tr><tr><td>AADT 2006</td></tr><tr><td>AADT 2005</td>... | <table><tr><td>DATA</td></tr><tr><td>37–95</td></tr><tr><td>95</td></tr><tr><td>37</td></tr><tr><td>35</td></tr><tr><td>65</td></tr><tr><td>250.08</td></tr><tr><td>115,150</td></tr><tr><td>113,900</td></tr><tr><td>118,520</td></tr><tr><td>117,930</td></tr><tr><td>117,800</td></tr><tr><td>115,060</td></tr><tr><td>113,30... |
a41359585e5c2096a03621a445e8ce4bbeacd266c020567fe4d6ceb8c557161c.png | complex | <table><tr><td colspan="2">Clinical features</td></tr><tr><td>Number of patients</td><td>13</td></tr><tr><td>Women/men</td><td>7/6</td></tr><tr><td>Age (years), mean ± SD</td><td>52.02 ± 19.01</td></tr><tr><td colspan="2"><i>Triggering factor</i></td></tr><tr><td> AOSD flare, number (%)</td><td>13 (100)</td><... | <table><tr><td colspan="2">Clinical features</td></tr><tr><td>Number of patients</td><td>13</td></tr><tr><td>Women/men</td><td>7/6</td></tr><tr><td>Age (years), mean ± SD</td><td>52.02 ± 19.01</td></tr><tr><td colspan="2">Triggering factor</td></tr><tr><td>AOSD flare, number (%)</td><td>13 (100)</td></tr><tr><td>Lympho... | <table><tr><td> mean ± SD</td><td>.69</td></tr><tr><td>HB (gr/dL), mean ± SD</td><td>9.19 ± 2.05</td></tr><tr><td>PLT (103/mL), mean ± SD</td><td>55.52 ± 46.54</td></tr><tr><td>Serum Ferritin (ng/mL), mean ± SD</td><td>4362.15 ± 7569.70</td></tr><tr><td>ESR (mm/hour), mean ± SD</td><td>71.23 ± 30.19</td></tr><tr><td>CR... |
eb959ed92aafe77c4198b5bb09be6b388317a1b7800b9d901a3f826d1c131169.png | complex | <table><tr><td>Section</td><td colspan="2">Conventional<sup>1</sup></td><td colspan="2">Enzymatic</td></tr><tr><td></td><td>%</td><td>(US$ × 100)</td><td>%</td><td>(US$ × 100)</td></tr><tr><td>Grain handling</td><td>8.2</td><td>6,500</td><td>8.7</td><td>6,500</td></tr><tr><td>Steeping (or pretreatment)</td><t... | <table><tr><td>Section</td><td colspan="2">Conventional1</td><td colspan="2">Enzymatic</td></tr><tr><td></td><td>%</td><td>(US$ × 100)</td><td>%</td><td>(US$ × 100)</td></tr><tr><td>Grain handling</td><td>8.2</td><td>6,500</td><td>8.7</td><td>6,500</td></tr><tr><td>Steeping (or pretreatment)</td><td>22.3</td><td>17,700... | <table><tr><td>Section</td><td colspan="2">Conventional1</td><td colspan="2">Enzymatic</td></tr><tr><td></td><td>%</td><td>(US$ × 100)</td><td>%</td><td>(US$ × 100)</td></tr><tr><td>Enzymatic treatment</td><td>0</td><td>0</td><td>4.9</td><td>3,700</td></tr><tr><td>Germ separation</td><td>13.5</td><td>10,700</td><td>14.... |
8c062e8c447611cf3611127e1271b679558944be47ce8f1ccbfea561fafaaeaa.png | simple | <table><tr><td>Domain</td><td>Scale/items</td><td>Parent-report</td><td>Self-report</td></tr><tr><td>Sexual socialization</td><td>Friendship skills of child</td><td>5 items</td><td>5 items</td></tr><tr><td></td><td>Social acceptance by peers</td><td>3 items</td><td>6 items</td></tr><tr><td></td><td>Romantic ability of ... | <table><tr><td>Domain</td><td>Scale/items</td><td>Parent-report</td><td>Self-report</td></tr><tr><td>Sexual socialization</td><td>Friendship skills of child</td><td>5 items</td><td>5 items</td></tr><tr><td></td><td>Social acceptance by peers</td><td>3 items</td><td>6 items</td></tr><tr><td></td><td>Romantic ability of ... | <table><tr><td></td><td>Perceived social competence</td><td>-</td><td>12 items</td></tr><tr><td></td><td>Sexual knowledge of the child according to parent</td><td>9 items</td><td>-</td></tr><tr><td>Sexual behavior</td><td>Separate items on age or context appropriate behaviors, intimate experiences including age of onse... |
a6b65d57cfed481d78e5a2d4bb4d059394613bbd479c5404cab3690756e09f49.png | complex | <table><tr><td></td><td colspan="2">Moderately/severely thin</td><td colspan="2">Mildly thin</td><td colspan="2">Overweight</td><td colspan="2">Obese</td></tr><tr><td>IMD decile</td><td>% (n)</td><td>RRR (95 % CI)</td><td>% (n)</td><td>RRR (95 % CI)</td><td>% (n)</td><td>RRR (95 % CI)</td><td>% (n)</td><td>RRR (95 % CI... | <table><tr><td></td><td colspan="2">Moderately/severely thin</td><td colspan="2">Mildly thin</td><td colspan="2">Overweight</td><td colspan="2">Obese</td></tr><tr><td>IMD decile</td><td>% (n)</td><td>RRR (95 % CI)</td><td>% (n)</td><td>RRR (95 % CI)</td><td>% (n)</td><td>RRR (95 % CI)</td><td>% (n)</td><td>RRR (95 % CI... | <table><tr><td>2</td><td>0.68 (822)</td><td>1.05 (0.96, 1.16)</td><td>4.64 (5 608)</td><td>0.96 (0.93, 1.00)</td><td>10.71 (12 932)</td><td>1.08 (1.06, 1.11)</td><td>2.42 (2 920)</td><td>1.20 (1.14, 1.27)</td></tr><tr><td>3</td><td>0.67 (775)</td><td>1.05 (0.95, 1.16)</td><td>4.59 (5 295)</td><td>0.96 (0.92, 1.00)</td>... |
7206c24f79c539be2c134bf7f9b51a7c0526679e5dc04c74976af8c6374df310.png | simple | <table><tr><td>Species</td><td>Ratio Gavage/i.p.</td><td>Mean Ratio</td></tr><tr><td><i>G. pacificus</i></td><td>>800, >1000, >340</td><td>>713</td></tr><tr><td><i>G. honu</i></td><td>395, 500</td><td>448</td></tr><tr><td><i>G. australes</i></td><td>54, 108, 80, 94, 126, 79, 100</td><td>92</td></tr><tr><td>... | <table><tr><td>Species</td><td>Ratio Gavage/i.p.</td><td>Mean Ratio</td></tr><tr><td>G. pacificus</td><td>>800, >1000, >340</td><td>>713</td></tr><tr><td>G. honu</td><td>395, 500</td><td>448</td></tr></table> | <table><tr><td>G. australes</td><td>54, 108, 80, 94, 126, 79, 100</td><td>92</td></tr><tr><td>G. cheloniae</td><td>369, 170</td><td>270</td></tr><tr><td>G. carpenteri</td><td>>16</td><td>-</td></tr><tr><td>F. paulensis</td><td>>63</td><td>-</td></tr><tr><td>G. polynesiensis</td><td>1.7</td><td>-</td></tr></table> |
fb5d82c6cbf925c57c7eef899ac515f89bae45cb6622120e44c803277761d6ea.png | simple | <table><tr><td>Up-regulated miRNAs</td><td>Down-regulated miRNAs</td></tr><tr><td>mmu-miR-2137</td><td>mmu-miR-1199-3p</td></tr><tr><td>mmu-miR-5131</td><td>mmu-miR-218-5p</td></tr><tr><td>mmu-miR-680</td><td>mmu-miR-7a-5p</td></tr><tr><td>mmu-miR-5130</td><td>mmu-miR-374c-5p</td></tr><tr><td>mmu-miR-144</td><td>mmu-mi... | <table><tr><td>Up-regulated miRNAs</td><td>Down-regulated miRNAs</td></tr><tr><td>mmu-miR-2137</td><td>mmu-miR-1199-3p</td></tr><tr><td>mmu-miR-5131</td><td>mmu-miR-218-5p</td></tr><tr><td>mmu-miR-680</td><td>mmu-miR-7a-5p</td></tr><tr><td>mmu-miR-5130</td><td>mmu-miR-374c-5p</td></tr></table> | <table><tr><td>Up-regulated miRNAs</td><td>Down-regulated miRNAs</td></tr><tr><td>mmu-miR-144</td><td>mmu-miR-449c-5p</td></tr><tr><td>mmu-miR-486</td><td>mmu-miR-450a-2-3p</td></tr><tr><td>mmu-miR-711</td><td>mmu-miR-696</td></tr><tr><td>mmu-miR-449a</td><td></td></tr><tr><td>mmu-miR-193</td><td></td></tr><tr><td>mmu-... |
387ded1e614fce03bf996c326e9af77523c2e99c9898cc423d1e456735239ad6.png | complex | <table><tr><td colspan="2">Data source</td><td colspan="3">Exhaustive search</td><td colspan="4">KL1LR</td></tr><tr><td></td><td></td><td colspan="2"># of GO terms (# in union)</td><td>AUC</td><td colspan="2"># of GO terms (# in union)</td><td>AUC</td><td>NCG</td></tr><tr><td>Protein-protein interactions</td><td>OPHID<... | <table><tr><td colspan="2">Data source</td><td colspan="3">Exhaustive search</td><td colspan="4">KL1LR</td></tr><tr><td></td><td></td><td colspan="2"># of GO terms (# in union)</td><td>AUC</td><td colspan="2"># of GO terms (# in union)</td><td>AUC</td><td>NCG</td></tr><tr><td>Protein-protein interactions</td><td>OPHID<... | <table><tr><td>Protein domain</td><td>Interpro</td><td>522</td><td>(697)</td><td>0.87</td><td>408</td><td>(518)</td><td>0.89</td><td>266</td></tr><tr><td></td><td>Pfam</td><td>600</td><td></td><td>0.86</td><td>311</td><td></td><td>0.89</td><td>210</td></tr><tr><td>Phenotype</td><td>MGI</td><td>213</td><td></td><td>0.87... |
f95ee00effdfc2670e1f8e4d440056df0a2cc1c6cfdd9f8207a871a30eaffd11.png | complex | <table><tr><td rowspan="2"> Criterion</td><td colspan="2">Score</td></tr><tr><td>No</td><td>Yes</td></tr><tr><td>Tortuous vessels</td><td>0</td><td>1</td></tr><tr><td>Large vessels</td><td>0</td><td>1</td></tr><tr><td>Leakage</td><td>0</td><td>1</td></tr><tr><td>Defective flux</td><td>0</td><td>1</td></tr></table> | <table><tr><td rowspan="2">Criterion</td><td colspan="2">Score</td></tr><tr><td>No</td><td>Yes</td></tr><tr><td>Tortuous vessels</td><td>0</td><td>1</td></tr><tr><td>Large vessels</td><td>0</td><td>1</td></tr></table> | <table><tr><td>Leakage</td><td>0</td><td>1</td></tr><tr><td>Defective flux</td><td>0</td><td>1</td></tr></table> |
a836372f29ba4f94e367d5d219f5c23a48f776bf6d553346fcef3bb0942f9374.png | simple | <table><tr><td>BMI classes</td><td>Mean</td><td>95% C.I</td><td>N</td></tr><tr><td>Normal Weight</td><td>21.7</td><td>20.8–22.6</td><td>84</td></tr><tr><td>Overweight</td><td>19.1</td><td>18.3–19.8</td><td>123</td></tr><tr><td>Obese Class I</td><td>18.2</td><td>17.3–19.1</td><td>77</td></tr><tr><td>Ob... | <table><tr><td></td><td>Mean</td><td></td><td>N</td></tr></table> | <table><tr><td>BMI classes</td><td></td><td>95% C.I</td><td></td></tr><tr><td>Normal Weight</td><td>21.7</td><td>20.8–22.6</td><td>84</td></tr><tr><td>Overweight</td><td>19.1</td><td>18.3–19.8</td><td>123</td></tr><tr><td>Obese Class I</td><td>18.2</td><td>17.3–19.1</td><td>77</td></tr><tr><td>Obese Class II</td><td>17... |
bbb2766af5760cf46c509963ae453f66512aa59aeb7c880158aa97e3ae53843b.png | simple | <table><tr><td></td><td>January</td><td>February</td><td>March</td><td>April</td><td>May</td><td>June</td><td>July</td><td>August</td><td>September</td><td>October</td><td>November</td><td>December</td><td>Total</td></tr><tr><td>Girls</td><td>7057</td><td>6897</td><td>7724</td><td>7414</td><td>7726</td><td>7303</td><td... | <table><tr><td></td><td>J</td><td>Febru</td><td></td><td>A</td><td>Ma</td><td></td><td>Ju</td><td>Augu</td><td></td><td></td><td>Novembe</td><td>D</td><td>T</td></tr></table> | <table><tr><td></td><td>anuary</td><td>ary</td><td>March</td><td>pril</td><td>y</td><td>June</td><td>ly</td><td>st</td><td>September</td><td>October</td><td>r</td><td>ecember</td><td>otal</td></tr><tr><td>Girls</td><td>7057</td><td>6897</td><td>7724</td><td>7414</td><td>7726</td><td>7303</td><td>7600</td><td>7544</td><... |
4dde64cab867c1bdcf95dcb274d7b66e6cf927716ae654b73df8647a359b7dc3.png | complex | <table><tr><td rowspan="2"> </td><td>Patients with IBS</td><td>Healthy controls</td><td rowspan="2"><i>p</i> value</td></tr><tr><td>(<i>n</i> = 89)</td><td>(<i>n</i> = 13)</td></tr><tr><td>Age in years, mean ± SD</td><td>45.7 ± 12.9</td><td>43.3 ± 8.6</td><td>0.595</td></tr><tr><td>Sex, male/female</td><... | <table><tr><td rowspan="2"></td><td>Patients with IBS</td></tr><tr><td>(n = 89)</td></tr><tr><td>Age in years, mean ± SD</td><td>45.7 ± 12.9</td></tr><tr><td>Sex, male/female</td><td>47/42</td></tr><tr><td>BMI, kg/m2</td><td>22.1 ± 5.8</td></tr><tr><td>Anxiety, mean ± SD</td><td>5.17 ± 3.16</td></tr><tr><td>Depression,... | <table><tr><td>Healthy controls</td><td rowspan="2">p value</td></tr><tr><td>(n = 13)</td></tr><tr><td>43.3 ± 8.6</td><td>0.595</td></tr><tr><td>9/4</td><td>0.266</td></tr><tr><td>24.5 ± 2.9</td><td>0.245</td></tr><tr><td>2.77 ± 1.64</td><td>0.009</td></tr><tr><td>3.54 ± 2.50</td><td>0.041</td></tr><tr><td>8.0 (0.0–35.... |
c7478d290c95b5a04ef89c20d47b6eaa3b63f2e4781ea670a60afe0c99e23cbe.png | simple | <table><tr><td>Variables</td><td>Overall survival(RR, 95% CI)</td><td><i>p</i></td><td>Disease-specific survival(RR, 95% CI))</td><td><i>p</i></td><td>Disease-free survival(RR, 95% CI)</td><td><i>p</i></td><td>Loco-regional control(RR, 95% CI)</td><td><i>p</i></td><td>Distant metastasis-free survival(RR, 95% CI)</td><t... | <table><tr><td>Variables</td><td>Overall survival(RR, 95% CI)</td><td>p</td><td>Disease-specific survival(RR, 95% CI))</td><td>p</td><td>Disease-free survival(RR, 95% CI)</td><td>p</td><td>Loco-regional control(RR, 95% CI)</td><td>p</td><td>Distant metastasis-free survival(RR, 95% CI)</td><td>p</td></tr><tr><td>T1-2 vs... | <table><tr><td>Variables</td><td>Overall survival(RR, 95% CI)</td><td>p</td><td>Disease-specific survival(RR, 95% CI))</td><td>p</td><td>Disease-free survival(RR, 95% CI)</td><td>p</td><td>Loco-regional control(RR, 95% CI)</td><td>p</td><td>Distant metastasis-free survival(RR, 95% CI)</td><td>p</td></tr><tr><td>GTVprn ... |
09c6c243eb6e428c47cc335c0355ba6194c9bbd0eb3266e3ccf70bc449663056.png | complex | <table><tr><td>Characteristics</td><td><i>n</i></td><td><i>P</i>-value<sup>a</sup><sup>,</sup><sup>b</sup></td><td>Hazard ratio<sup>a</sup><sup>,</sup><sup>b</sup></td><td>95% CI<sup>a</sup><sup>,</sup><sup>b</sup></td></tr><tr><td colspan="5">Age</td></tr><tr><td>< 20</td><td>18 (82%)</td><td></td><td></td><td></td... | <table><tr><td>Characteristics</td></tr><tr><td>Age</td></tr><tr><td>< 20</td></tr><tr><td>> 20</td></tr><tr><td>Median</td></tr><tr><td>Gender</td></tr><tr><td>Male</td></tr><tr><td>Female</td></tr><tr><td>Tumor volume (cm3)</td></tr><tr><td>Median</td></tr><tr><td>Range</td></tr><tr><td>Tumor surface (cm2)</td></tr><... | <table><tr><td>n</td><td>P-valuea,b</td><td>Hazard ratioa,b</td><td>95% CIa,b</td></tr><tr><td colspan="4">Age</td></tr><tr><td>18 (82%)</td><td></td><td></td><td></td></tr><tr><td>4 (18%)</td><td>0.06</td><td>0.16</td><td>2.3 × 10−10–1.3</td></tr><tr><td>13</td><td></td><td></td><td></td></tr><tr><td colspan="4">Gende... |
98f89ff9aa0f2e589d9d6f8a52f1016f3fb1bf7a7d79c08cfc9698ce6a861a09.png | simple | <table><tr><td>Date</td><td>Advance</td><td>Applications</td></tr><tr><td>1670s</td><td>Microscope invented by Leeuwenhoek</td><td>Visualize bacteria, protozoa</td></tr><tr><td>1850s</td><td>Puerperal fever identified as infectious and interventions implemented by Semmelweis [23]</td><td>Hospital infection control moti... | <table><tr><td>Date</td><td>Advance</td><td>Applications</td></tr><tr><td>1670s</td><td>Microscope invented by Leeuwenhoek</td><td>Visualize bacteria, protozoa</td></tr><tr><td>1850s</td><td>Puerperal fever identified as infectious and interventions implemented by Semmelweis [23]</td><td>Hospital infection control moti... | <table><tr><td>1890s</td><td>Identification of microbial etiologies for tuberculosis, anthrax, and so on; Koch’s postulates</td><td>Targeted diagnostics, therapeutics, and move from syndromic diagnosis to pathogen identification</td></tr><tr><td>1900-1930s</td><td>Discovery of filterable animal viruses [24]</td><td>Inf... |
ce92307b438370f5580bc5b6826c71a604f88fa1790883916fd53135bbf9332b.png | simple | <table><tr><td>Conditions</td><td>Biological Process</td><td>FDRp-value</td><td>Molecular Function</td><td>FDRp-value</td></tr><tr><td>Control</td><td>response to abiotic or biotic stimulus</td><td>2.8e-19</td><td>transcription factor activity</td><td>3.4e-04</td></tr><tr><td></td><td>response to stress</td><td>1.6e-13... | <table><tr><td>Conditions</td><td>Biological Process</td><td>FDRp-value</td><td>Molecular Function</td><td>FDRp-value</td></tr><tr><td>Control</td><td>response to abiotic or biotic stimulus</td><td>2.8e-19</td><td>transcription factor activity</td><td>3.4e-04</td></tr><tr><td></td><td>response to stress</td><td>1.6e-13... | <table><tr><td>Conditions</td><td>Biological Process</td><td>FDRp-value</td><td>Molecular Function</td><td>FDRp-value</td></tr><tr><td></td><td>response to stress</td><td>6.0e-07</td><td>transferase activity</td><td>2.3e-03</td></tr><tr><td></td><td>other biological processes</td><td>3.3e-03</td><td>other enzyme activi... |
a4989750a2dda864ebc579c8a78a9f8eb511dd6b111feef8d30d2802d4c56556.png | complex | <table><tr><td rowspan="2"></td><td>Did not require ICU(<i>n</i> = 249)</td><td>Required ICU (severe)(<i>n</i> = 18)</td><td rowspan="2"><i>P</i>b value</td></tr><tr><td>N (%)</td><td>N (%)</td></tr><tr><td>Any medical risk factor a</td><td>115 (46.2)</td><td>11 (61.1)</td><td>.22</td></tr><tr><td>Influenza B strain</t... | <table><tr><td rowspan="2"></td><td>Did not require ICU(n = 249)</td><td>Required ICU (severe)(n = 18)</td><td rowspan="2">Pb value</td></tr><tr><td>N (%)</td><td>N (%)</td></tr><tr><td>Any medical risk factor a</td><td>115 (46.2)</td><td>11 (61.1)</td><td>.22</td></tr><tr><td>Influenza B strain</td><td>47 (19.0)</td><... | <table><tr><td rowspan="2"></td><td>Did not require ICU(n = 249)</td><td>Required ICU (severe)(n = 18)</td><td rowspan="2">Pb value</td></tr><tr><td>N (%)</td><td>N (%)</td></tr><tr><td>Proportion less than 2 y of age</td><td>150 (60.2)</td><td>14 (77.8)</td><td>.14</td></tr><tr><td>Antiviral prescribed</td><td>34 (13.... |
08fd2a0cad135e41181b932b258fa6759b00db0e909dd311a6b95bb73ba038ce.png | complex | <table><tr><td>Baseline characteristics</td><td></td><td>Missed scheduled appointments (%)</td><td>RR</td><td>95 % CI</td><td><i>p</i> (value)</td></tr><tr><td rowspan="2">Sex</td><td>Female</td><td>4/153 (2.6)</td><td>1</td><td></td><td></td></tr><tr><td>Male</td><td>33/304 (10.9)</td><td>4.2</td><td>1.5–11.5</t... | <table><tr><td>Baseline characteristics</td><td></td></tr><tr><td rowspan="2">Sex</td><td>Female</td></tr><tr><td>Male</td></tr><tr><td>Age (years)</td><td><25</td></tr><tr><td></td><td>25–64</td></tr><tr><td></td><td>≥65</td></tr><tr><td>HIV-Status</td><td>Negative</td></tr><tr><td></td><td>Positive</td></tr><tr><td><... | <table><tr><td>Missed scheduled appointments (%)</td><td>RR</td><td>95 % CI</td><td>p (value)</td></tr><tr><td>4/153 (2.6)</td><td>1</td><td></td><td></td></tr><tr><td>33/304 (10.9)</td><td>4.2</td><td>1.5–11.5</td><td>0.004</td></tr><tr><td>5/82 (6.1)</td><td>1</td><td></td><td></td></tr><tr><td>31/360 (8.6)</td><td>1... |
46921367575651aa16bd7a894dcbc987c9e708e3d8318f88a0d3895202c0189a.png | complex | <table><tr><td>Explanatory variable</td><td>Coefficient ± Standar Error</td><td><i>P</i></td></tr><tr><td colspan="3">Body Fat at follow-up equation, kg</td></tr><tr><td> Leisure time physical activity at follow-up, METs/wk</td><td>−0.215 ± 0.091</td><td>0.019</td></tr><tr><td> Calorie Intake at follow-... | <table><tr><td>Explanatory variable</td><td>Coefficient ± Standar Error</td></tr><tr><td colspan="2">Body Fat at follow-up equation, kg</td></tr><tr><td>Leisure time physical activity at follow-up, METs/wk</td><td>−0.215 ± 0.091</td></tr><tr><td>Calorie Intake at follow-up, 100 kcal</td><td>0.328 ± 0.142</td></tr><tr><... | <table><tr><td>P</td></tr><tr><td>Body Fat at follow-up equation, kg</td></tr><tr><td>0.019</td></tr><tr><td>0.021</td></tr><tr><td>0.001</td></tr><tr><td>< 0.001</td></tr><tr><td>< 0.001</td></tr><tr><td>Leisure time physical activity at follow-up equation, METs/wk</td></tr><tr><td>0.020</td></tr><tr><td>0.045</td></t... |
885348360a75b1e94d40f18dee9595953e38215d7904c2fb978d4aebf0d64977.png | complex | <table><tr><td>Brain regions</td><td> </td><td>Voxels</td><td><i>X</i> (MNI)</td><td><i>Y</i> (MNI)</td><td><i>Z</i> (MNI)</td><td><i>T</i> value</td></tr><tr><td>High BrAC group < control</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td rowspan="2"> Superior frontal gyrus</td><td>R</td><... | <table><tr><td>Brain regions</td><td></td><td>Voxels</td><td>X (MNI)</td><td>Y (MNI)</td><td>Z (MNI)</td><td>T value</td></tr><tr><td>High BrAC group < control</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Superior frontal gyrus</td><td>R</td><td>750</td><td>15</td><td>21</td><td>57</td><td>−4.... | <table><tr><td>Superior frontal gyrus</td><td>R</td><td>39</td><td>12</td><td>39</td><td>−24</td><td>−3.7952</td></tr><tr><td>Inferior frontal gyrus</td><td>R</td><td>37</td><td>54</td><td>21</td><td>18</td><td>−4.4388</td></tr><tr><td>Hippocampal gyrus</td><td>R</td><td>39</td><td>18</td><td>−6</td><td>−33</td><td>−4.... |
27ced2db3f8c24ec1cca5d270792e966d17fd60d5c7f282a69ea16680adb4462.png | simple | <table><tr><td>Gene</td><td>Acc. No</td><td>Primer sequence (5′ to 3′)</td></tr><tr><td><i>Pparg</i> (mouse)</td><td>NM_001127330</td><td>F: GACCACTCGCATTCCTTT</td></tr><tr><td> </td><td> </td><td>R: CCACAGACTCGGCACTCA</td></tr><tr><td><i>Fabp4</i> (mouse)</td><td>NM_024406</td><td>F: AAATCACCGCAGACGACA</td... | <table><tr><td>Gene</td><td>Acc. No</td></tr><tr><td>Pparg (mouse)</td><td>NM_001127330</td></tr><tr><td></td><td></td></tr><tr><td>Fabp4 (mouse)</td><td>NM_024406</td></tr><tr><td></td><td></td></tr><tr><td>Runx2 (mouse)</td><td>NM_001146038</td></tr><tr><td></td><td></td></tr><tr><td>Osterix (mouse)</td><td>NM_130458... | <table><tr><td>Primer sequence (5′ to 3′)</td></tr><tr><td>F: GACCACTCGCATTCCTTT</td></tr><tr><td>R: CCACAGACTCGGCACTCA</td></tr><tr><td>F: AAATCACCGCAGACGACA</td></tr><tr><td>R: CACATTCCACCACCAGCT</td></tr><tr><td>F: ACTTCCTGTGCTCCGTGCTG</td></tr><tr><td>R: TCGTTGAACCTGGCTACTTGG</td></tr><tr><td>F: ACCAGGTCCAGGCAACAC<... |
fe6c4929fda8844b175be8fa59cbd75836ecb1604876ba88bf149578c97da2a2.png | complex | <table><tr><td rowspan="3">Dataset</td><td colspan="6">Sum of Weights</td></tr><tr><td colspan="3">Deterministic Model</td><td colspan="3">Stochastic Model</td></tr><tr><td>Before Failure</td><td>After Failure</td><td>W-GAP</td><td>Before Failure</td><td>After Failure</td><td>W-GAP</td></tr><tr><td>Dataset_1</td><td>37... | <table><tr><td rowspan="3">Dataset</td><td colspan="6">Sum of Weights</td></tr><tr><td colspan="3">Deterministic Model</td><td colspan="3">Stochastic Model</td></tr><tr><td>Before Failure</td><td>After Failure</td><td>W-GAP</td><td>Before Failure</td><td>After Failure</td><td>W-GAP</td></tr><tr><td>Dataset_1</td><td>37... | <table><tr><td>Dataset_8</td><td>34</td><td>25.8</td><td>24.1%</td><td>32.5</td><td>30.9</td><td>4.9%</td></tr><tr><td>Dataset_9</td><td>34.5</td><td>26.9</td><td>22.0%</td><td>32.4</td><td>32.4</td><td>0.0%</td></tr><tr><td>Dataset_10</td><td>29.4</td><td>26.1</td><td>11.2%</td><td>28.3</td><td>28.3</td><td>0.0%</td><... |
4039b2734334d5809c8645d80c30fbf0f70321b27a284f2e6e8ec880bb8d0864.png | complex | <table><tr><td></td><td colspan="2">Girls</td><td>Boys</td></tr><tr><td>Goodness-of-fit statistics</td><td>1-factor model</td><td>2- factor model</td><td>1-factor model</td></tr><tr><td>χ<sup>2</sup></td><td>8.13</td><td>4.41</td><td>4.44</td></tr><tr><td>df</td><td>5</td><td>4</td><td>5</td></tr><tr><td>p</td><td... | <table><tr><td></td><td colspan="2">Girls</td><td>Boys</td></tr></table> | <table><tr><td>Goodness-of-fit statistics</td><td>1-factor model</td><td>2- factor model</td><td>1-factor model</td></tr><tr><td>χ2</td><td>8.13</td><td>4.41</td><td>4.44</td></tr><tr><td>df</td><td>5</td><td>4</td><td>5</td></tr><tr><td>p</td><td>.15</td><td>.35</td><td>.49</td></tr><tr><td>RMSEA</td><td>.028</td><td>... |
e15065c932c2541de2dd9d1deca51c3101d72e57d22cdd6d178cddb2ff53eb52.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2"></td><td rowspan="2"></td><td>First outbreak (October 2013)</td><td></td><td>Second outbreak (July 2014)</td><td></td></tr><tr><td colspan="2">Water temperature: 23 °C</td><td colspan="2">Water temperature: 26 °C</td></tr><tr><td>Cage</td><td>Date stocked</td><t... | <table><tr><td rowspan="2"></td><td rowspan="2"></td><td rowspan="2"></td><td>First outbreak (October 2013)</td><td></td><td>Second outbreak (July 2014)</td></tr><tr><td colspan="2">Water temperature: 23 °C</td><td>Water temperature: 26 °C</td></tr><tr><td>Cage</td><td>Date stocked</td><td>Age at stocking (months)</td>... | <table><tr><td></td></tr><tr><td>Water temperature: 26 °C</td></tr><tr><td>Cumulative mortality (%)</td></tr><tr><td>4,86</td></tr><tr><td>5,3</td></tr><tr><td>4,76</td></tr><tr><td>2,23</td></tr></table> |
5c8b632deefe62dfe146ff9e84e0987afc0f144c8cee28a658430018792cc9ed.png | complex | <table><tr><td>Treatment</td><td colspan="2">Days from transplant to initial bolting (d)</td><td colspan="2">Days from transplant to 50% bolting (d)</td><td colspan="2">Bolting rate by 30 April (%)</td></tr><tr><td> </td><td>2011</td><td>2012</td><td>2011</td><td>2012</td><td>2011</td><td>2012</td></tr><tr><td>Grand me... | <table><tr><td>Treatment</td><td colspan="2">Days from transplant to initial bolting (d)</td><td colspan="2">Days from transplant to 50% bolting (d)</td><td colspan="2">Bolting rate by 30 April (%)</td></tr><tr><td></td><td>2011</td><td>2012</td><td>2011</td><td>2012</td><td>2011</td><td>2012</td></tr><tr><td>Grand mea... | <table><tr><td>Treatment</td><td colspan="2">Days from transplant to initial bolting (d)</td><td colspan="2">Days from transplant to 50% bolting (d)</td><td colspan="2">Bolting rate by 30 April (%)</td></tr><tr><td></td><td>2011</td><td>2012</td><td>2011</td><td>2012</td><td>2011</td><td>2012</td></tr><tr><td>Cultivars... |
090c8168b7e69df332f615d544c57fa69508654b1bacf50189c61c3233081086.png | complex | <table><tr><td rowspan="2">Brain region</td><td>BA</td><td>Cluster sizes</td><td>t-value</td><td>P value</td><td colspan="3">Peak MNI coodinate</td></tr><tr><td colspan="2">(voxels)</td><td colspan="2">(Corr.)</td><td>X</td><td>Y</td><td>Z</td></tr><tr><td>R medial prefrontal cortex</td><td>8</td><td>12</td><td>6.02</t... | <table><tr><td rowspan="2">Brain region</td></tr><tr></tr><tr><td>R medial prefrontal cortex</td></tr><tr><td>R middle frontal gyrus</td></tr><tr><td>L middle temporal gyrus</td></tr><tr><td>R superior temporal gyrus</td></tr><tr><td>L primary somatosensory cortex</td></tr><tr><td>R inferior parietal lobule</td></tr><t... | <table><tr><td>BA</td><td>Cluster sizes</td><td>t-value</td><td>P value</td><td colspan="3">Peak MNI coodinate</td></tr><tr><td colspan="2">(voxels)</td><td colspan="2">(Corr.)</td><td>X</td><td>Y</td><td>Z</td></tr><tr><td>8</td><td>12</td><td>6.02</td><td><.05</td><td>9</td><td>27</td><td>57</td></tr><tr><td>9</td><t... |
4b1d8a4cbf03c98390d4d4ec431f86aa43fb09f9e644a0d77d7a8792550999d8.png | complex | <table><tr><td>Category</td><td>Treatment adherence barriers</td></tr><tr><td rowspan="2">Stigma related factors</td><td>▪ Fear of disclosure of child’s status to the teachers and family members by parents</td></tr><tr><td>▪ Segregation by teachers and other children</td></tr><tr><td rowspan="4">Lack ... | <table><tr><td>Category</td><td>Treatment adherence barriers</td></tr><tr><td rowspan="2">Stigma related factors</td><td>▪ Fear of disclosure of child’s status to the teachers and family members by parents</td></tr><tr><td>▪ Segregation by teachers and other children</td></tr><tr><td>Lack of s</td><td>▪ Inadequate supp... | <table><tr><td rowspan="4">upportive environment at home</td><td>nts</td></tr><tr><td>➢ Parents move to farming areas without one to follow up on child’s treatment schedule</td></tr><tr><td>➢ Men do not provide enough treatment adherence support</td></tr><tr><td>➢ Extended family members do not provide support</td></tr... |
8d0225008b7b48603909bccc03608dd06a86821a010fa8703d4395ef8970876b.png | complex | <table><tr><td rowspan="2"></td><td>Factor</td></tr><tr><td>1</td></tr><tr><td>Me siento cansado y desanimado cuando me levanto por las mañanas</td><td>0.612</td></tr><tr><td>Mis músculos están tensos y doloridos</td><td>0.650</td></tr><tr><td>Tengo ataques de pánico</td><td>0.388</td></tr><tr><... | <table><tr><td rowspan="2"></td><td>Factor</td></tr><tr><td>1</td></tr><tr><td>Me siento cansado y desanimado cuando me levanto por las mañanas</td><td>0.612</td></tr><tr><td>Mis músculos están tensos y doloridos</td><td>0.650</td></tr><tr><td>Tengo ataques de pánico</td><td>0.388</td></tr><tr><td>Rechino los dient... | <table><tr><td rowspan="2"></td><td>Factor</td></tr><tr><td>1</td></tr><tr><td>Tengo dificultad para concentrarme</td><td>0.436</td></tr><tr><td>Tengo problemas en la piel como resequedad, picor o sarpullido</td><td>0.299</td></tr><tr><td>El estrés hace que mis síntomas físicos empeoren</td><td>0.587</td></tr><tr><t... |
5b785a269eb49f6dad43714f4c71fb9af31f0eb1ca0f916bddfbd4614dc30dc1.png | complex | <table><tr><td rowspan="2">Symbol</td><td colspan="2">2 Days <i>vs.</i> Ctr</td><td colspan="2">4 Days <i>vs.</i> Ctr</td><td colspan="2">7 Days <i>vs.</i> Ctr</td></tr><tr><td><i>P</i>-Value</td><td>Fold Change</td><td><i>P</i>-Value</td><td>Fold Change</td><td><i>P</i>-Value</td><td>Fold Change</td></tr><tr><td>ANKRD... | <table><tr><td rowspan="2">Symbol</td><td colspan="2">2 Days vs. Ctr</td><td colspan="2">4 Days vs. Ctr</td><td colspan="2">7 Days vs. Ctr</td></tr><tr><td>P-Value</td><td>Fold Change</td><td>P-Value</td><td>Fold Change</td><td>P-Value</td><td>Fold Change</td></tr><tr><td>ANKRD50</td><td>2.82 × 10−2</td><td>−1.323</td>... | <table><tr><td>CCDC88C</td><td>1.82 × 10−1</td><td>−1.363</td><td>1.51 × 10−1</td><td>−1.398</td><td>6.70 × 10−3</td><td>−2.041</td></tr><tr><td>CYP24A1</td><td>9.28 × 10−1</td><td>−1.027</td><td>8.44 × 10−1</td><td>−1.060</td><td>3.32 × 10−2</td><td>−2.011</td></tr><tr><td>DGKH</td><td>3.48 × 10−5</td><td>−1.619</td><... |
4be53f7b3e3c6ef7e6203e7bd900ee7482f20c6399a5f4d14024e2d81fe662cc.png | simple | <table><tr><td>Patient Safety Culture Composite</td><td>Definition: The extent to which....</td><td>Number of Survey Items</td></tr><tr><td>1. Communication openness</td><td>Staff will freely speak up if they see something that may negatively affect patient care, and feel free to question those with more authority</td>... | <table><tr><td>Patient Safety Culture Composite</td><td>Definition: The extent to which....</td><td>Number of Survey Items</td></tr><tr><td>1. Communication openness</td><td>Staff will freely speak up if they see something that may negatively affect patient care, and feel free to question those with more authority</td>... | <table><tr><td>6. Nonpunitive response to error</td><td>Staff feel that their mistakes are not held against them, and mistakes are not kept in their personnel file</td><td>3</td></tr><tr><td>7. Organizational learning--Continuous improvement</td><td>Mistakes have led to positive changes and changes are evaluated for th... |
4a4be3ef8497afcb7ebc9291452ac4b1ac01fe1fe30c459f9b92f23bf05757d8.png | simple | <table><tr><td>Oligonucleotide</td><td>Sequence</td></tr><tr><td>NUCKS F (forward)</td><td>5'-AATTCACAGGAAGATAGTGAGG-3'</td></tr><tr><td>NUCKS R (reverse)</td><td>5'-TCACTGTAG CCTTTAGTCTGGG-3'</td></tr><tr><td>GAPDH forward</td><td>5'-ATGGGGAAGGTGAAGGTCGGAGTC-3'</td></tr><tr><td>GAPDH reverse</td><td>5'-GAACATGGGGGCGTC... | <table><tr><td>Oligonucleotide</td><td>Sequence</td></tr><tr><td>NUCKS F (forward)</td><td>5'-AATTCACAGGAAGATAGTGAGG-3'</td></tr><tr><td>NUCKS R (reverse)</td><td>5'-TCACTGTAG CCTTTAGTCTGGG-3'</td></tr><tr><td>GAPDH forward</td><td>5'-ATGGGGAAGGTGAAGGTCGGAGTC-3'</td></tr></table> | <table><tr><td>GAPDH reverse</td><td>5'-GAACATGGGGGCGTCAGCAGAG-3'</td></tr><tr><td>NUCKS Fq (forward, real-time PCR)</td><td>5'-TCTGATGATGCAGATGAAGATTA-3'</td></tr><tr><td>NUCKS Rq (reverse, real-time PCR)</td><td>5'-CTGCTGAGTGAGAATCATCC-3'</td></tr><tr><td>NUCKS FL probe</td><td>5'-TCTTGGTCTTCACATCTTTGTCTTCT-FL-3'</td... |
cc8735b169ca4cda682511a99d58758ee793e20b241737be165e5c7f975290ac.png | complex | <table><tr><td rowspan="2">Characteristics of the partner at the first sexual relation</td><td colspan="2">Sex (%)</td></tr><tr><td>Women</td><td>Men</td></tr><tr><td>Type of relationship</td><td></td><td></td></tr><tr><td><i>Namorado </i>(steady boyfriend/girlfriend)</td><td>86</td><td>45</td></tr><tr><td>Husband/wife... | <table><tr><td rowspan="2">Characteristics of the partner at the first sexual relation</td><td colspan="2">Sex (%)</td></tr><tr><td>Women</td><td>Men</td></tr><tr><td>Type of relationship</td><td></td><td></td></tr><tr><td>Namorado (steady boyfriend/girlfriend)</td><td>86</td><td>45</td></tr><tr><td>Husband/wife/living... | <table><tr><td rowspan="2">Characteristics of the partner at the first sexual relation</td><td colspan="2">Sex (%)</td></tr><tr><td>Women</td><td>Men</td></tr><tr><td>Yes</td><td>50</td><td>76</td></tr><tr><td>No</td><td>50</td><td>24</td></tr></table> |
43053b2f8580b32dc4c9c9290987e1b6ed7bed4bc4458fd7f096c873ce314a7c.png | complex | <table><tr><td rowspan="2">Type of Patient/Specimen Type</td><td colspan="2">2011</td><td colspan="2">2012</td><td colspan="2">2013</td><td colspan="2">2014</td></tr><tr><td>%</td><td><i>n</i><sup>1</sup></td><td>%</td><td><i>n</i><sup>1</sup></td><td>%</td><td><i>n</i><sup>1</sup></td><td>%</td><td><i>n</i><sup>1</sup... | <table><tr><td rowspan="2">Type of Patient/Specimen Type</td><td colspan="2">2011</td><td colspan="2">2012</td><td colspan="2">2013</td></tr><tr><td>%</td><td>n1</td><td>%</td><td>n1</td><td>%</td><td>n1</td></tr><tr><td>Inpatients</td><td>88.5</td><td>96</td><td>81.0</td><td>126</td><td>86.1</td><td>216</td></tr><tr><... | <table><tr><td colspan="2">2014</td></tr><tr><td>%</td><td>n1</td></tr><tr><td>90.7</td><td>140</td></tr><tr><td>47.1</td><td>140</td></tr></table> |
24bc14970a39984765c577d7f062bfd25683ea96c0bcdfac870522601351509e.png | simple | <table><tr><td>Demographic</td><td>Number (%)</td></tr><tr><td>Gender</td><td> </td></tr><tr><td>Male</td><td>64 (43.2)</td></tr><tr><td>Female</td><td>84 (56.8)</td></tr><tr><td>Marital status</td><td> </td></tr><tr><td>Single</td><td>57 (38.5)</td></tr><tr><td>Married</td><td>44 (29.7)</td></tr><tr><td>Widowed</td><t... | <table><tr><td>Demographic</td><td>Number (%)</td></tr><tr><td>Gender</td><td></td></tr><tr><td>Male</td><td>64 (43.2)</td></tr><tr><td>Female</td><td>84 (56.8)</td></tr><tr><td>Marital status</td><td></td></tr><tr><td>Single</td><td>57 (38.5)</td></tr><tr><td>Married</td><td>44 (29.7)</td></tr><tr><td>Widowed</td><td>... | <table><tr><td>Employment status</td><td></td></tr><tr><td>Unemployed</td><td>68 (45.9)</td></tr><tr><td>Employed</td><td>39 (26.3)</td></tr><tr><td>Homemaker</td><td>35 (23.6)</td></tr><tr><td>Retired/other</td><td>5 (3.4)</td></tr><tr><td>Unknown</td><td>1 (0.7)</td></tr></table> |
b9b18391a1f1573dc62bdee1caafcc5f72e4ac42329269d0c7b1c799d89c2311.png | complex | <table><tr><td rowspan="3">Indices of clinical burden of Sickle Cell Disease</td><td colspan="2">Children</td></tr><tr><td><i>n</i></td><td>%</td></tr><tr><td>Duration of care since diagnosis</td><td></td><td></td></tr><tr><td>≤ 6 months</td><td>22</td><td>9.8</td></tr><tr><td>> 6 months</td><td>203</td><td>90... | <table><tr><td rowspan="3">Indices of clinical burden of Sickle Cell Disease</td><td colspan="2">Children</td></tr><tr><td>n</td><td>%</td></tr><tr><td colspan="2"></td></tr><tr><td>Duration of care since diagnosis</td><td></td><td></td></tr><tr><td>≤ 6 months</td><td>22</td><td>9.8</td></tr><tr><td>> 6 months</td><td>... | <table><tr><td rowspan="3">Indices of clinical burden of Sickle Cell Disease</td><td colspan="2">Children</td></tr><tr><td>n</td><td>%</td></tr><tr><td colspan="2"></td></tr><tr><td>Twice</td><td>85</td><td>37.8</td></tr><tr><td>> twice</td><td>92</td><td>40.9</td></tr><tr><td>Previous blood transfusion (range = 0–10)<... |
fe808ab93885c8fdf0c8ea34b46410eb52531abebc40a073c9473d7ed1c6f5b1.png | simple | <table><tr><td></td><td>(A) 176 drug products</td><td>(B) 45 drug products</td><td>(C) 162 drug products</td></tr><tr><td>Therapeutic group</td><td></td><td></td><td></td></tr><tr><td> A—alimentary tract and metabolism</td><td>18</td><td>8</td><td>17</td></tr><tr><td> B—blood and blood-forming organs</td><t... | <table><tr><td></td><td>(A) 176 drug products</td><td>(B) 45 drug products</td><td>(C) 162 drug products</td></tr><tr><td>Therapeutic group</td><td></td><td></td><td></td></tr><tr><td>A—alimentary tract and metabolism</td><td>18</td><td>8</td><td>17</td></tr><tr><td>B—blood and blood-forming organs</td><td>9</td><td>3<... | <table><tr><td>Re-examination dates</td><td></td><td></td><td></td></tr><tr><td>January 2009 to December 2009</td><td>45</td><td>6</td><td>42</td></tr><tr><td>January 2010 to December 2010</td><td>44</td><td>13</td><td>42</td></tr><tr><td>January 2011 to December 2011</td><td>30</td><td>9</td><td>27</td></tr><tr><td>Ja... |
2e8b6f5db011f0db8c537b5d5af6f39d50108ea06ec69d99db499a644877cf38.png | simple | <table><tr><td>Variables</td><td>Mean±SD</td></tr><tr><td>BMI (Kg/m<sup>2</sup>)</td><td>43.40 ± 20.20</td></tr><tr><td>Post-Load PG (mg/dL)</td><td>80.00±15.80</td></tr><tr><td>SBP (mmHg)</td><td>127.60 ± 26.70</td></tr><tr><td>DBP (mmHg)</td><td>80.00 ± 15.80</td></tr><tr><td>FPG (mg/dL)</td>... | <table><tr><td>Variables</td></tr><tr><td>BMI (Kg/m2)</td></tr><tr><td>Post-Load PG (mg/dL)</td></tr><tr><td>SBP (mmHg)</td></tr><tr><td>DBP (mmHg)</td></tr><tr><td>FPG (mg/dL)</td></tr><tr><td>Waist Circumference (CM)</td></tr></table> | <table><tr><td>Mean±SD</td></tr><tr><td>43.40 ± 20.20</td></tr><tr><td>80.00±15.80</td></tr><tr><td>127.60 ± 26.70</td></tr><tr><td>80.00 ± 15.80</td></tr><tr><td>93.40 ± 19.80</td></tr><tr><td>182.84 ± 101.10</td></tr></table> |
3f804b6eaef6a1c4ffbf1c578e4f6c57959d13b54076512babceeb45eb5d4ae3.png | simple | <table><tr><td>Indication for surgery</td><td>Frequency</td><td>Percentage</td></tr><tr><td>Bleeding duodenal ulcers not responding to either medical or endoscopic treatment</td><td>5</td><td>26.3</td></tr><tr><td>Gastric malignancy</td><td>6</td><td>31.6</td></tr><tr><td>Gastrointestinal stroma tumour</td><td>8</td><t... | <table><tr><td>Indication for surgery</td><td>Frequency</td></tr><tr><td>Bleeding duodenal ulcers not responding to either medical or endoscopic treatment</td><td>5</td></tr><tr><td>Gastric malignancy</td><td>6</td></tr><tr><td>Gastrointestinal stroma tumour</td><td>8</td></tr></table> | <table><tr><td>Percentage</td></tr><tr><td>26.3</td></tr><tr><td>31.6</td></tr><tr><td>42.1</td></tr></table> |
77ee500d0e90417bece89b36b8cb9cf247b2b8c20e5b863f4d4535ab1888d7c6.png | complex | <table><tr><td></td><td colspan="4">Survey I (<i>n</i> = 2200)</td><td colspan="4">Survey II (<i>n</i> = 2203)</td></tr><tr><td></td><td colspan="2">VL</td><td colspan="2">H</td><td colspan="2">VL</td><td colspan="2">H</td></tr><tr><td></td><td>OR</td><td>95 % CI</td><td>OR</td><td>95 % CI</td><td>OR</td><td>95 % CI</t... | <table><tr><td></td><td colspan="4">Survey I (n = 2200)</td><td colspan="4">Survey II (n = 2203)</td></tr><tr><td></td><td colspan="2">VL</td><td colspan="2">H</td><td colspan="2">VL</td><td colspan="2">H</td></tr><tr><td></td><td>OR</td><td>95 % CI</td><td>OR</td><td>95 % CI</td><td>OR</td><td>95 % CI</td><td>OR</td><... | <table><tr><td>Parent smokes</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>No</td><td>___</td><td></td><td>___</td><td></td><td>___</td><td></td><td>___</td><td></td></tr><tr><td>Yes</td><td>.76</td><td>.57/1.03</td><td>2.10</td><td>1.62/2.73</td><td>.77</td><td>.56/1.06</td><... |
c0336e1c0d2ddebd5f78d8bb57fee92b9d9096924286bb943a5654dd5efa806d.png | simple | <table><tr><td>Subfamily</td><td>Gene identification</td><td></td><td>Domain organisation</td><td>Amino acids</td></tr><tr><td>ABCB</td><td></td><td></td><td></td><td></td></tr><tr><td> ABCB1</td><td>PFE1150w</td><td>PfMDR1</td><td>(MSD-NBD)<sub>2</sub></td><td>1419</td></tr><tr><td> ABCB2</td><td>PF14_0455</td><td>PfM... | <table><tr><td>Subfamily</td><td>Gene identification</td><td></td><td>Domain organisation</td><td>Amino acids</td></tr><tr><td>ABCB</td><td></td><td></td><td></td><td></td></tr><tr><td>ABCB1</td><td>PFE1150w</td><td>PfMDR1</td><td>(MSD-NBD)2</td><td>1419</td></tr><tr><td>ABCB2</td><td>PF14_0455</td><td>PfMDR2</td><td>M... | <table><tr><td>ABCI</td><td></td><td></td><td></td><td></td></tr><tr><td>ABCI1</td><td>PF14_0133</td><td></td><td>NBD</td><td>347</td></tr><tr><td>ABCI2</td><td>PF14_0321</td><td></td><td>NBD</td><td>171</td></tr><tr><td>ABCI3</td><td>PFC0875w</td><td></td><td>MSD-NBD-MSD</td><td>3133</td></tr></table> |
2881fab5c060ab899e3eb7f7d7407d7b5532ebfc39a4f0daecae8c4599288656.png | complex | <table><tr><td></td><td colspan="3">Climate model</td></tr><tr><td>Time period</td><td>Median</td><td>Minimal</td><td>Maximal</td></tr><tr><td>1986–2005</td><td>20.7 (27.4)</td><td></td><td></td></tr><tr><td>2026–2045</td><td>22.9 (30.0)</td><td>21.6 (28.9)</td><td>22.9 (30.2)</td></tr><tr><td>2081–21... | <table><tr><td></td><td colspan="3">Climate model</td></tr></table> | <table><tr><td>Time period</td><td>Median</td><td>Minimal</td><td>Maximal</td></tr><tr><td>1986–2005</td><td>20.7 (27.4)</td><td></td><td></td></tr><tr><td>2026–2045</td><td>22.9 (30.0)</td><td>21.6 (28.9)</td><td>22.9 (30.2)</td></tr><tr><td>2081–2100</td><td>26.1 (35.1)</td><td>24.6 (32.4)</td><td>28.5 (37.7)</td></t... |
8490452076a40dbcbf9cd27587d474139423e3235d473eb2f714956d5eb8bdea.png | complex | <table><tr><td>Patient</td><td>Gene</td><td>Varianta</td><td>Patient cancer historyb</td></tr><tr><td colspan="4"><i>Discovered cancer gene mutations (163 disease-gene panel)</i>c</td></tr><tr><td>BRCA1.60</td><td>CHEK2</td><td>c.573+1G>A</td><td>Breast-47, 49</td></tr><tr><td>BRCA1.61</td><td>ATM</td><td>p.Glu2290&... | <table><tr><td>Patient</td><td>Gene</td></tr><tr><td colspan="2">Discovered cancer gene mutations (163 disease-gene panel)c</td></tr><tr><td>BRCA1.60</td><td>CHEK2</td></tr><tr><td>BRCA1.61</td><td>ATM</td></tr><tr><td>BRCA2.7</td><td>RAD50</td></tr><tr><td>BRCA2.13</td><td>ATM</td></tr><tr><td>BRCA2.65</td><td>CDKN2B<... | <table><tr><td>Varianta</td><td>Patient cancer historyb</td></tr><tr><td colspan="2">Discovered cancer gene mutations (163 disease-gene panel)c</td></tr><tr><td>c.573+1G>A</td><td>Breast-47, 49</td></tr><tr><td>p.Glu2290⁎</td><td>Unaffected-24</td></tr><tr><td>c.3G>A</td><td>Breast-49</td></tr><tr><td>p.Glu1978⁎</td><t... |
94afe6212d82708cc1cb4d94161c9e0e565ab31c0941b1ea31443428a65bb1c4.png | complex | <table><tr><td>DPC*</td><td>Type</td><td colspan="3">Pathological findings†</td></tr><tr><td></td><td></td><td>Lung</td><td>Inguinal Lymph Nodes</td><td>Heart</td></tr><tr><td>14</td><td>I</td><td>Moderate focal/multifocal bronchointerstitial pneumonia (3/3)</td><td>Lymphadenopathy (3/3)</td><td>Mild multifocal p... | <table><tr><td>DPC*</td><td></td><td colspan="3">Patholo</td></tr></table> | <table><tr><td></td><td>Type</td><td colspan="3">gical findings†</td></tr><tr><td></td><td></td><td>Lung</td><td>Inguinal Lymph Nodes</td><td>Heart</td></tr><tr><td>14</td><td>I</td><td>Moderate focal/multifocal bronchointerstitial pneumonia (3/3)</td><td>Lymphadenopathy (3/3)</td><td>Mild multifocal perivascular lymph... |
d87c27328353c713d2c7e9469ece0c74cfeb74f52f5d80ff715ee2467756aa80.png | complex | <table><tr><td rowspan="2" colspan="2"> </td><td colspan="2">Believes PPM has exposed him/her to hazardous chemicals</td><td colspan="2">Felt he/she was coughing, breathless or wheezing due to something in the air</td><td colspan="2">Believes the industry will affect children born in the future in the community</td><td... | <table><tr><td rowspan="2" colspan="2"></td><td colspan="2">Believes PPM has exposed him/her to hazardous chemicals</td><td colspan="2">Felt he/she was coughing, breathless or wheezing due to something in the air</td><td colspan="2">Believes the industry will affect children born in the future in the community</td><td ... | <table><tr><td>Environmental awareness/knowledge</td><td>Willing to participate in environmental campaigns</td><td></td><td></td><td>2.297‡</td><td>0.713-7.396</td><td>2.985*</td><td>1.031-8.645</td><td></td><td></td><td>3.127*</td><td>1.100-8.888</td></tr><tr><td rowspan="2">Main Information source</td><td>Friends/rel... |
58a2debeb215df21f123557f4b0e882ee0c55a6cefbb5eecfc6449db6dd18bf9.png | simple | <table><tr><td>Hemi</td><td>Region</td><td><i>ß</i></td><td>SE</td><td><i>p</i>-value (uncorrected)</td><td>FDR-corrected <i>p</i>-value</td></tr><tr><td>R</td><td>Nucleus accumbens</td><td>−0.23</td><td>0.058</td><td>0.000077</td><td>0.0055</td></tr><tr><td>L</td><td>Inferior parietal cortex</td><td>−... | <table><tr><td>Hemi</td><td>Region</td><td>ß</td><td>SE</td><td>p-value (uncorrected)</td><td>FDR-corrected p-value</td></tr><tr><td>R</td><td>Nucleus accumbens</td><td>−0.23</td><td>0.058</td><td>0.000077</td><td>0.0055</td></tr><tr><td>L</td><td>Inferior parietal cortex</td><td>−0.38</td><td>0.10</td><td>0.00014</td>... | <table><tr><td>R</td><td>Caudate nucleus</td><td>−0.28</td><td>0.081</td><td>0.00064</td><td>0.011</td></tr><tr><td>L</td><td>Putamen</td><td>−0.24</td><td>0.071</td><td>0.00068</td><td>0.011</td></tr><tr><td>L</td><td>Caudate nucleus</td><td>−0.23</td><td>0.071</td><td>0.0011</td><td>0.014</td></tr><tr><td>R</td><td>A... |
502b78ffce5b5a8d913937dd1ffa177486235eeb756660c97b33df049a0d3a5b.png | complex | <table><tr><td>Outcome</td><td>General anaesthesia</td><td>Neuraxial anaesthesia</td><td>Combination</td></tr><tr><td rowspan="2">Major VTE and VTE-related mortality</td><td>4.2%*</td><td>3.1%*</td><td>3.1%</td></tr><tr><td>(73/1731)</td><td>(101/3305)</td><td>(35/1147)</td></tr><tr><td>MBE</td><td>1.2%</td><td>1.4%</t... | <table><tr><td>Outcome</td><td>General anaesthesia</td></tr><tr><td rowspan="2">Major VTE and VTE-related mortality</td><td>4.2%*</td></tr><tr><td>(73/1731)</td></tr><tr><td>MBE</td><td>1.2%</td></tr><tr><td></td><td>(27/2311)</td></tr><tr><td>MBE/CRBE</td><td>4.9%</td></tr><tr><td></td><td>(114/2311)</td></tr></table> | <table><tr><td>Neuraxial anaesthesia</td><td>Combination</td></tr><tr><td>3.1%*</td><td>3.1%</td></tr><tr><td>(101/3305)</td><td>(35/1147)</td></tr><tr><td>1.4%</td><td>1.2%</td></tr><tr><td>(59/4212)</td><td>(19/1539)</td></tr><tr><td>5.6%</td><td>5.7%</td></tr><tr><td>(237/4212)</td><td>(88/1539)</td></tr></table> |
8196dc74ed4cf5380cf6514e4c78d449dd2bd132459eedc62f2c8b67021ab63e.png | complex | <table><tr><td rowspan="2"><i>R<sub>FB</sub></i></td><td rowspan="2">Mineral Filler Quantity(g)</td><td colspan="3">Mineral Filler A <i>V<sub>g</sub></i> = 0.26</td><td colspan="3">Mineral Filler B <i>V<sub>g</sub></i> = 0.11</td><td colspan="3">Mineral Filler C <i>V<sub>g</sub></i> = 0.19</td><td colspan="3">Mineral F... | <table><tr><td rowspan="2">RFB</td><td rowspan="2">Mineral Filler Quantity(g)</td><td colspan="3">Mineral Filler A Vg = 0.26</td><td colspan="3">Mineral Filler B Vg = 0.11</td><td colspan="3">Mineral Filler C Vg = 0.19</td><td colspan="3">Mineral Filler D Vg = 0.32</td></tr><tr><td>S(g)</td><td>F(g)</td><td>S/F</td><td... | <table><tr><td rowspan="2">RFB</td><td rowspan="2">Mineral Filler Quantity(g)</td><td colspan="3">Mineral Filler A Vg = 0.26</td><td>Mineral Filler B Vg = 0.11</td><td colspan="3">Mineral Filler C Vg = 0.19</td><td colspan="3">Mineral Filler D Vg = 0.32</td></tr><tr><td>S(g)</td><td>F(g)</td><td>S/F</td><td>F(g)</td><t... |
729e33bd92994207fafcbcd59c3805ea7058131095800d9e65f7bc0ce72af3db.png | simple | <table><tr><td></td><td>Sanger technology</td><td>454 FLX technology</td><td>Sanger + 454 FLX</td></tr><tr><td>Total number of reads</td><td>14,120</td><td>789,105</td><td>-</td></tr><tr><td>Average length of read (bases)</td><td>780</td><td>218</td><td>-</td></tr><tr><td>Total number of reads in the assembly</td><td>1... | <table><tr><td></td><td>Sanger technology</td><td>454 FLX technology</td><td>Sanger + 454 FLX</td></tr></table> | <table><tr><td>Total number of reads</td><td>14,120</td><td>789,105</td><td>-</td></tr><tr><td>Average length of read (bases)</td><td>780</td><td>218</td><td>-</td></tr><tr><td>Total number of reads in the assembly</td><td>12,032</td><td>466,737</td><td>478,769</td></tr><tr><td>Total number of contigs</td><td>2,120</td... |
b07295b39cbff853bb64eb20332203ca4078e909fd4eeedbe866099cc1385f51.png | complex | <table><tr><td> </td><td> </td><td>Sal</td><td>VH</td><td>SS</td><td>ES5</td><td>ES10</td></tr><tr><td rowspan="2">F0</td><td>Area</td><td>160.3 ± 23.6</td><td>164.5 ± 13.6</td><td>165.3 ± 12.5</td><td>160 ± 12.1</td><td>166.5 ± 26.5</td></tr><tr><td>WCI</td><td>00.0 ± 00.0</td><td>00.0 &#... | <table><tr><td></td><td></td><td>Sal</td><td>VH</td><td>SS</td><td>ES5</td><td>ES10</td></tr><tr><td rowspan="2">F0</td><td>Area</td><td>160.3 ± 23.6</td><td>164.5 ± 13.6</td><td>165.3 ± 12.5</td><td>160 ± 12.1</td><td>166.5 ± 26.5</td></tr><tr><td>WCI</td><td>00.0 ± 00.0</td><td>00.0 ± 00.0</td><td>00.0 ± 00.0</td><td... | <table><tr><td></td><td></td><td>Sal</td><td>VH</td><td>SS</td><td>ES5</td><td>ES10</td></tr><tr><td></td><td>CI</td><td>.4</td><td>1.5</td><td>7 ± 13.1</td><td>± 11.7</td><td>12.6</td></tr><tr><td rowspan="2">F2</td><td>Area</td><td>30.0 ± 11.3</td><td>25.2 ± 12.9</td><td>35.3 ± 10.4</td><td>15.9 ± 8.8∗</td><td>16.8 ±... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.